{"title":"Cancer Treating Drugs","description":"Cancer treating drugs, also known as oncology medications, are used to target and destroy cancer cells, inhibit their growth, and prevent the spread of cancer throughout the body. These drugs encompass a variety of treatments, including chemotherapy, targeted therapy, immunotherapy, and hormone therapy, each working in different ways to combat specific types of cancer. They may be employed in conjunction with surgery and radiation therapy to improve treatment outcomes, reduce tumor size, alleviate symptoms, and enhance the quality of life for cancer patients.","products":[{"product_id":"gardasil-9-vials-hpv-vaccine-10-pack","title":"Gardasil 9 Human Papillomavirus Vaccine (HPV vaccine) Recombinant, 20 mcg - 60 mcg (10-Pack) **Requires Refrigeration (RX)","description":"\u003cp\u003eGardasil 9 is a Human Papillomavirus (HPV) vaccine used to protect against cancers caused by HPV, including cervical, anal, and throat cancers, as well as genital warts. It offers protection against nine HPV types, significantly reducing the risk of infection. Administered through a series of injections, this vaccine plays a crucial role in preventive healthcare. It is effective in promoting immune protection and enhancing overall public health by reducing HPV-related disease prevalence.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a leading vaccine designed to provide robust protection against certain strains of Human Papillomavirus (HPV). Manufactured by Merck, this recombinant vaccine targets nine HPV types—6, 11, 16, 18, 31, 33, 45, 52, and 58—responsible for the majority of HPV-related cancers and diseases. With its advanced formulation, Gardasil 9 empowers individuals to safeguard their health and reduce the risk of developing HPV-related cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Strengths:\u003c\/strong\u003e Offers antigen levels ranging from 20 mcg to 60 mcg, tailored to confer optimal immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Protection:\u003c\/strong\u003e Covers nine HPV types responsible for approximately 90% of cervical cancer cases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e Approved for use in both males and females, typically starting from ages 9 to 45.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Recombinant vaccine, meaning it uses a safe, non-infectious virus-like particle (VLP) to elicit an immune response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Administered via intramuscular injection, typically in a series of two or three doses depending on the age and health status of the recipient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGardasil 9 works by introducing non-infectious VLPs resembling the HPV virus to the body. This prompts the immune system to produce antibodies, equipping the body to recognize and neutralize the actual virus if exposed in the future. The vaccine does not contain live virus, ensuring safety while effectively stimulating a protective immune response.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVaccination Schedule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 9-14:\u003c\/strong\u003e Two doses, with a second dose given 6-12 months after the first.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 15-45 and Immunocompromised Individuals:\u003c\/strong\u003e Three doses, with the second and third doses given two and six months after the first, respectively.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute of Administration:\u003c\/strong\u003e Administered intramuscularly, typically in the upper arm or thigh.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e Immediate medical attention is required for severe allergic reactions, such as difficulty breathing, wheezing, hives, or swelling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Breastfeeding:\u003c\/strong\u003e Not recommended for pregnant women; if pregnancy is discovered post-vaccination, notify your healthcare provider. Consult a doctor before receiving the vaccine while breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSyncope (Fainting):\u003c\/strong\u003e Patients should be observed for at least 15 minutes post-vaccination to manage any immediate adverse reactions, including fainting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInjection-site reactions: Pain, swelling, or redness\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eDizziness\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost side effects are mild and resolve on their own. Contact your healthcare provider if you experience persistent or severe symptoms.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a pivotal tool in the prevention of HPV-related diseases. Consult your healthcare provider to learn if Gardasil 9 is appropriate for you or your loved ones, and take proactive steps to protect against HPV.\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":12099154575432,"sku":"00006-4121-02","price":4200.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gardasil-9-Human-Papillomavirus-Vaccine-Syringes.jpg?v=1742574664"},{"product_id":"carboplatin-for-injection-450mg-45-ml","title":"Carboplatin Injection 450 mg \/ 45 mL Multi-dose Vial 45 mL, Preservative Free (RX)","description":"\u003ch1\u003eCarboplatin Injection 450 mg\/45 mL (Multi-dose vial, Preservative-Free)\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin injection is a platinum-based chemotherapy (antineoplastic) drug. It is supplied as a sterile, preservative-free aqueous solution (10 mg carboplatin per mL) in a multi-dose vial. Each 45 mL vial contains 450 mg of carboplatin and 10 mg mannitol per mL (mannitol is an inert stabilizer). The solution is colorless to pale yellow and is formulated for intravenous use (no preservatives are added)\u003c\/span\u003e.\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eUses:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e Carboplatin is primarily used to treat ovarian cancer. It is indicated for the \u003cstrong\u003efirst-line (initial) treatment of advanced ovarian carcinoma\u003c\/strong\u003e in established combination with other chemotherapeutic agents (for example, carboplatin plus cyclophosphamide). It is also indicated for \u003cstrong\u003epalliative treatment of recurrent ovarian cancer\u003c\/strong\u003e in patients who have received prior chemotherapy (including those who relapsed after cisplatin therapy). (In practice, carboplatin is often given with other agents such as paclitaxel in gynecologic cancers.) Physicians may also use carboplatin off-label for other tumors (e.g. lung, head and neck, etc.), but the main approved use is ovarian carcinoma.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eHow to Use:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin injection is given by slow intravenous infusion under healthcare supervision. The drug is typically infused over at least 15 minutes (often longer). Treatment cycles are usually repeated every 3–4 weeks, as determined by patient response and blood counts. The dose is personalized based on body surface area and kidney function, often calculated by the Calvert formula: dose (mg) = AUC × (GFR + 25), where AUC is the target area-under-curve. Carboplatin solution is typically further diluted in IV fluid (for example, 5% dextrose or normal saline) for infusion. Since no preservative is present, the prepared solution should be used within 8 hours of dilution and any unused portion discarded. (Unlike cisplatin, routine hydration or forced diuresis is generally not required during carboplatin administration \u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eCarboplatin vs Cisplatin\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism:\u003c\/strong\u003e Both carboplatin and cisplatin are platinum(II) coordination compounds that form DNA cross-links and inhibit DNA synthesis in cancer cells. Carboplatin is a derivative of cisplatin with similar action but different side-effect profiles.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eEfficacy:\u003c\/strong\u003e In ovarian cancer trials, carboplatin (with cyclophosphamide) achieved survival outcomes equivalent to cisplatin combinations. This means carboplatin is generally as effective as cisplatin for that indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eToxicity differences:\u003c\/strong\u003e Carboplatin causes \u003cstrong\u003eless kidney (nephro-) and nerve (neuro-) toxicity\u003c\/strong\u003e than cisplatin. Cisplatin is highly nephrotoxic and emetogenic (causes severe nausea\/vomiting), whereas carboplatin has milder kidney effects and is better tolerated (causing less nausea). Conversely, carboplatin produces \u003cstrong\u003emore bone marrow suppression\u003c\/strong\u003e (especially thrombocytopenia) than cisplatin. For example, treatment with carboplatin often requires careful monitoring of blood counts and may cause significant anemia or bleeding risk, while cisplatin causes these effects to a lesser extent. Carboplatin’s peripheral neuropathy and hearing effects are also generally milder than those of cisplatin.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHematologic:\u003c\/strong\u003e The most common toxic effect is bone marrow suppression. Carboplatin frequently causes \u003cstrong\u003eanemia, leukopenia, and thrombocytopenia.\u003c\/strong\u003e This can lead to fatigue, infection or bleeding; blood counts must be checked before each cycle. (In fact, myelosuppression is dose-limiting with carboplatin.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal:\u003c\/strong\u003e Nausea and vomiting are fairly common (though typically less severe than with cisplatin). Diarrhea and loss of appetite (anorexia) may also occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeurologic:\u003c\/strong\u003e Peripheral neuropathy (tingling, numbness or burning in the hands and feet) can occur. Notably, the incidence of serious neuropathy is relatively low, but risk increases with cumulative doses or prior cisplatin use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHair and General:\u003c\/strong\u003e Temporary hair loss (alopecia) is possible. Other common effects include fatigue and general weakness.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Allergic (hypersensitivity) reactions can occur, sometimes acutely during infusion. Symptoms range from mild rash to severe anaphylaxis (hives, difficulty breathing, swelling of face\/lips). Monitoring during infusion is important.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRenal\/Ototoxicity:\u003c\/strong\u003e Although less than with cisplatin, carboplatin can still affect kidneys and hearing. Mild kidney function changes are common (↑ BUN\/creatinine in some patients) and ~25% incidence of nephrotoxicity has been reported. Hearing impairment (tinnitus or hearing loss) occurs in a minority of patients (e.g. ~15%). Electrolyte disturbances (↓Mg, ↓K) may also occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther:\u003c\/strong\u003e Carboplatin may also cause elevated liver enzymes, fever, and local injection-site reactions. Patients are usually given antiemetic and other supportive medications to manage side effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways follow the prescribing information and your medical team’s instructions. This summary is not exhaustive; patients should consult their oncologist or pharmacist for personalized advice on carboplatin therapy.\u003c\/p\u003e\n\u003cp\u003eBrand: Pfizer Hospira\u003cbr\u003eSize: 450mg \/ 45 mL\u003cbr\u003eNDC: 61703-0339-50\u003cbr\u003eUPC: 361703-339508\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eBuy Carboplatin for Injection 450mg \/ 45 mL online at Mountainside Medical Equipment.\u003c\/p\u003e\n\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":12109892976712,"sku":"61703-0339-50","price":129.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Carboplatin_for_Injection_450mg_45_mL.jpg?v=1600352979"},{"product_id":"carboplatin-for-injection-150mg-15-ml","title":"Carboplatin Injection 150 mg \/ 15 mL Multiple Dose Vial 15 mL (RX)","description":"\u003cp\u003eCarboplatin for Injection 150mg \/ 15 mL Multiple Dose Vial 15 mL is a form of chemotherapy medication used to treat various types of cancer, including ovarian, lung, and prostate cancer. It belongs to a class of drugs known as platinum-based compounds. Carboplatin helps to stop the growth and spread of cancer cells by interfering with their DNA replication process. It is administered by injection into a vein and is usually given in multiple doses over a period of weeks or months. The 150mg strength, along with the 15 mL vial, refers to the amount of drug contained in each vial and the volume of liquid it is mixed with for administration.\u003c\/p\u003e\n\u003cp\u003eCarboplatin for Injection 150mg\/15mL is a chemotherapeutic medication used in the treatment of various types of cancer, including ovarian, lung, and breast cancers. It is also known by its brand name, Paraplatin.\u003c\/p\u003e\n\u003cp\u003eCarboplatin works by interfering with the growth and reproduction of cancer cells. It is in the class of medications known as platinum-based antineoplastic agents, which work by binding to and damaging DNA within the cancer cells, eventually leading to their death.\u003c\/p\u003e\n\u003cp\u003eSpecifically, carboplatin works by attaching to guanine, a building block of DNA, which disrupts the formation of new DNA strands and eventually prevents the cancer cells from reproducing.\u003c\/p\u003e\n\u003cp\u003eCarboplatin is administered intravenously, meaning it is given directly into a vein, and is typically used in combination with other chemotherapy drugs. It is often given in cycles, with short periods of treatment followed by periods of rest to allow the body to recover.\u003c\/p\u003e\n\u003cp\u003eOverall, Carboplatin for Injection 150mg\/15mL works to slow or stop the growth and spread of cancer cells, helping to reduce the size of tumors and ultimately treat the cancer.\u003c\/p\u003e\n\u003cp\u003eCarboplatin for Injection 150mg \/ 15 mL must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer treatment. Carboplatin can cause a severe decrease in the number of blood cells in your bone marrow. Carboplatin is used to treat ovarian cancer. Carboplatin is also used for other types of cancer, including lung, head and neck, endometrial, esophageal, bladder, breast, and cervical; central nervous system or germ cell tumors; osteogenic sarcoma; and as preparation for a stem cell or bone marrow transplant.\u003c\/p\u003e\n\u003cp\u003eCarboplatin is in a class of drugs known as platinum-containing compounds (metal salt). It is an alkylating agent. It works against cancer cells in the “resting phase” and slows or stops the cells growth. Many chemo medications identify and attack cancer cells because they reproduce quickly.\u003c\/p\u003e\n\u003cp\u003eBrand: Pfizer Hospira\u003cbr\u003eSize: 150mg \/ 15 mL\u003cbr\u003eNDC: 61703-0339-22\u003cbr\u003eUPC: 617030339224\u003c\/p\u003e\n\u003cp\u003eBuy Carboplatin for Injection 150mg \/ 15 mL online at Mountainside Medical Equipment.\u003c\/p\u003e\n\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":12109893468232,"sku":"61703-0339-22","price":59.35,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Carboplatin-for-Injection-150mg-15-mL.jpg?v=1715171564"},{"product_id":"neulasta-pegfilgrastim-shot-6-mg-syringe","title":"Neulasta (pegfilgrastim) Shot 6 mg Syringe","description":"\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e\n\u003cp\u003eNeulasta (pegfilgrastim) shot is a man-made form of a protein that stimulates the growth of white blood cells in your body. White blood cells help your body fight against infection. Pegfilgrastim is used to prevent neutropenia (a lack of certain white blood cells) that is caused by receiving chemotherapy.\u003c\/p\u003e\n\u003cp\u003eNeulasta (pegfilgrastim) shot is used following chemotherapy to help fight infection. Some chemotherapy will reduce the number of neutrophils in your body. Although Neulasta is not a treatment for cancer, it does help the body to make new neutrophils.\u003c\/p\u003e\n\u003cp\u003eNote: This is not a chemotherapy drug. This medication is usually given at least 24 hours after chemotherapy to stimulate the growth of new, healthy, white blood cells (WBC). Pegfilgrastim is a longer acting form of filgrastim and the manufacturer recommends that it should not be given within 14 days prior to chemotherapy.\u003c\/p\u003e\n\u003cp\u003eBrand: Amgen\u003c\/p\u003e\n\u003cp\u003eSize: 0.6 mL\u003c\/p\u003e\n\u003cp\u003eNDC: 55513-0190-01\u003c\/p\u003e\n\u003cp\u003eUPC: 355513190015\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eBuy Neulasta (pegfilgrastim) Shot 6 mg Syringe online at Mountainside Medical Equipment.\u003c\/p\u003e\n\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":12173201473608,"sku":"55513-0190-01","price":8720.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Neulasta-Shot.jpg?v=1600372018"},{"product_id":"dexamethasone-sodium-phosphate-10-ml-for-injection-25-pack","title":"Dexamethasone Sodium Phosphate Injection 1 mL (Decadron Shot) 25\/Pack (Rx)","description":"\u003ch1\u003e#1 Trusted Corticosteroid for Rapid Inflammation, Allergy, and Immune Control\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eDexamethasone Sodium Phosphate Injection 1 mL (Decadron Shot)\u003c\/strong\u003e from \u003cstrong\u003eHikma Pharmaceuticals\u003c\/strong\u003e is the top-rated, physician-preferred corticosteroid injection for emergency and acute care. Used worldwide to treat severe inflammation, allergic reactions, immune disorders, asthma, shock, and COVID-19 complications, this fast-acting injectable is hospital-grade and ready for urgent or routine use. Supplied in bulk packs (25 vials) for convenient access and clinical efficiency in ERs, urgent care, oncology, and specialty practices.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eDexamethasone Sodium Phosphate Injection is a sterile, injectable corticosteroid solution that delivers dexamethasone, a potent synthetic glucocorticoid (steroid) medication. It’s used to treat various conditions that respond to corticosteroids, including inflammation, allergies, immune disorders, and certain cancers.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eUses\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSevere allergies or asthma attacks\u003c\/li\u003e\n\u003cli\u003eShock (from certain causes)\u003c\/li\u003e\n\u003cli\u003eCerebral edema (swelling in the brain)\u003c\/li\u003e\n\u003cli\u003eAdrenal insufficiency (adrenal crisis)\u003c\/li\u003e\n\u003cli\u003eRheumatoid arthritis and other autoimmune conditions\u003c\/li\u003e\n\u003cli\u003eManagement of some cancers (as part of chemotherapy regimens)\u003c\/li\u003e\n\u003cli\u003ePrevention\/treatment of nausea and vomiting from chemotherapy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eEach pack contains 25 ready-to-use 1 mL ampoules, ensuring convenience and accuracy in dosage for both hospital and clinic settings.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eOrder Dexamethasone Sodium Phosphate Injection 1 mL (Decadron Shot) by Hikma Today!\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 00641-0367-25 | \u003cstrong\u003eUPC:\u003c\/strong\u003e 306410367253 \u003cstrong\u003eFast Shipping | 100% Authentic | Hospital-Grade | Bulk Pricing\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGet ultimate clinical confidence, rapid symptom management, and optimal patient outcomes with this industry-leading injectable dexamethasone solution from Hikma.\u003c\/p\u003e\n\u003cp\u003eacting corticosteroid solution.\u003c\/p\u003e","brand":"Hikma Pharmaceuticals","offers":[{"title":"Default Title","offer_id":12194286829640,"sku":"00641-0367-25","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dexamethasone-Sodium-Phosphate-1-mL-by-Hikma-NDC-00641-0367-25.jpg?v=1748525091"},{"product_id":"fareston-tablets-60-mg","title":"Fareston Tablets 60 mg","description":"\u003cp\u003eFareston Tablets (toremifene citrate) 60 mg used to treat patients with breast cancer. Fareston (toremifene citrate) is an estrogen agonist\/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.\u003c\/p\u003e\n\u003cp\u003eThe dosage of Fareston is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.\u003c\/p\u003e\n\u003cp\u003eBrand: Prostrakan Pharmaceutical Group\u003cbr\u003eSize: 30 Tablets\u003cbr\u003eStrength: 60 mg\u003cbr\u003eNDC: 42747-0327-30\u003cbr\u003eUPC: 342747327300\u003c\/p\u003e\n\u003cp\u003eBuy Fareston Tablets 60 mg to treat breast cancer online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Prostrakan Pharmaceutical Group","offers":[{"title":"Default Title","offer_id":12227315400776,"sku":"42747-0327-30","price":1799.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Fareston-Tablets.jpg?v=1600361429"},{"product_id":"methotrexate-for-injection-250-mg-ml-vial-10ml","title":"Methotrexate Injection 250 mg\/mL Vial 10 mL (RX)","description":"\u003cp\u003eMethotrexate Injection is a trusted treatment for cancer, rheumatoid arthritis, and psoriasis. Methotrexate Injection delivers fast relief, reduces inflammation, and slows disease progression. Choose Methotrexate Injection for effective care. Methotrexate Injection supports your health with proven results. Related keywords: chemotherapy, rheumatoid arthritis treatment, psoriasis therapy, cancer medication.\u003c\/p\u003e\n\u003cp\u003eMethotrexate for Injection by Fresenius Kabi is a sterile, preservative-free solution formulated at 250 mg\/mL, supplied in a 10 mL single-use vial. This high-potency antineoplastic agent is designed for intravenous (IV), intramuscular (IM), intra-arterial (IA), or intrathecal (IT) administration by experienced healthcare professionals. Methotrexate is widely trusted for its role in the treatment of various cancers and certain autoimmune diseases.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhat It Is Used For\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eMethotrexate for Injection is indicated for the management of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCertain neoplastic diseases, including \u003cstrong\u003eacute lymphoblastic leukemia (ALL)\u003c\/strong\u003e, breast cancer, lung cancer, head and neck cancer, and osteosarcoma\u003c\/li\u003e\n\u003cli\u003eSevere, recalcitrant, disabling \u003cstrong\u003epsoriasis\u003c\/strong\u003e unresponsive to other therapies\u003c\/li\u003e\n\u003cli\u003eRheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) when response to other treatments has been inadequate\u003c\/li\u003e\n\u003cli\u003eOther off-label autoimmune or inflammatory conditions as determined by your doctor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDosage \u0026amp; CDC Guidelines\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003eDosage\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOncologic Uses\u003c\/strong\u003e: Doses typically range from 10 mg\/m² to 30 mg\/m² weekly, or as continuous infusion, depending on the disease protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePsoriasis \u0026amp; Rheumatoid Arthritis\u003c\/strong\u003e: Lower doses, generally 7.5 mg to 25 mg total per week, adjusted according to clinical response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlways individualize\u003c\/strong\u003e dosage based on indication, patient status, and physician guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eCDC Guidelines\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThe Centers for Disease Control and Prevention (CDC) and other authorities recommend methotrexate be administered only by healthcare professionals familiar with its uses, toxicities, and safety precautions.\u003c\/li\u003e\n\u003cli\u003eRigorous monitoring (CBC, liver, and renal function tests) is required before and during therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDetails \u0026amp; Features\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 250 mg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVolume:\u003c\/strong\u003e 10 mL single-use vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Fresenius Kabi, renowned for its pharmaceutical quality and reliability\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, preservative-free formulation\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEasy-to-read labeling and tamper-evident packaging\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSuitable for multiple routes of administration (IV, IM, IT, IA)\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eMethotrexate is an antimetabolite and antifolate drug. It inhibits dihydrofolate reductase, preventing the conversion of dihydrofolate to tetrahydrofolate. This blocks DNA synthesis, repair, and cellular replication, primarily targeting rapidly dividing cells, such as cancerous, psoriatic, and immune cells.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003e\u003cstrong\u003eTo be administered only by qualified healthcare providers in a clinical setting.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eInspect vial, ensuring solution is clear and free from particles.\u003c\/li\u003e\n\u003cli\u003eDosage and route are prescribed based on patient’s condition and treatment protocol.\u003c\/li\u003e\n\u003cli\u003eUse appropriate aseptic technique; avoid mixing with incompatible solutions.\u003c\/li\u003e\n\u003cli\u003eDispose of any unused portion; single-use only.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eALWAYS refer to the full prescribing information for detailed instructions.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethotrexate can cause serious, life-threatening side effects:\u003c\/strong\u003e liver toxicity, lung disease, bone marrow suppression, infections, and gastrointestinal toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot for use in pregnancy\u003c\/strong\u003e; causes fetal death or congenital anomalies. Women of childbearing age should use effective contraception during and after therapy.\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with liver, renal, or pre-existing bone marrow impairment.\u003c\/li\u003e\n\u003cli\u003eMay increase the risk of infections. Monitor closely.\u003c\/li\u003e\n\u003cli\u003eNot recommended for routine use in children unless specialized expertise is available.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eCommon side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea, vomiting, diarrhea\u003c\/li\u003e\n\u003cli\u003eStomatitis (mouth sores)\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003cli\u003eDizziness or headache\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects may involve:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere bone marrow suppression (anemia, bleeding, infections)\u003c\/li\u003e\n\u003cli\u003eHepatotoxicity (elevated liver enzymes, liver failure)\u003c\/li\u003e\n\u003cli\u003ePulmonary toxicity (pneumonitis)\u003c\/li\u003e\n\u003cli\u003eRenal impairment\u003c\/li\u003e\n\u003cli\u003ePhotosensitivity or rash\u003c\/li\u003e\n\u003cli\u003eAllergic reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf any severe or unusual symptoms occur, seek immediate medical attention.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eConsult your healthcare provider for full prescribing information and before starting Methotrexate for Injection.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Fresenius Kabi","offers":[{"title":"Default Title","offer_id":12227713695816,"sku":"63323-0123-10","price":63.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Methotrexate-for-Injection-250-mg-Fresenius-63323-0123-10.jpg?v=1748609891"},{"product_id":"methotrexate-for-injection-25-mg-ml-vial-2ml","title":"Methotrexate Sodium Injection 50 mg Per 2 mL (25 mg\/mL) Multi-Dose Vials 2 mL x 5\/Pack (RX)","description":"\u003cp\u003eMethotrexate Sodium Injection is used to treat certain types of cancer, such as breast cancer, lung cancer, and leukemia, as well as autoimmune diseases like rheumatoid arthritis and severe psoriasis. It functions as an antimetabolite by interfering with DNA synthesis, thus inhibiting the growth of cancer cells and suppressing immune system activity. Administered intravenously or intramuscularly, Methotrexate requires careful dosing and monitoring to mitigate potential side effects, including liver toxicity and bone marrow suppression, ensuring safe and effective treatment.\u003c\/p\u003e\n\u003cp\u003ePfizer Injectables presents Methotrexate Sodium Injection, a well-established medication used in the treatment of certain types of cancer, severe psoriasis, and rheumatoid arthritis. Each multi-dose vial contains 25 mg\/mL of methotrexate sodium, featuring an effective formulation that meets a range of therapeutic needs. Packaged in a convenient set of five 2 mL vials, this product is ideal for healthcare professionals seeking a versatile, high-quality option for delivering precise doses over multiple administrations. Pfizer's commitment to safety and efficacy ensures that Methotrexate Sodium Injection remains a trusted choice in various medical settings.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Each 2 mL vial contains 25 mg\/mL of methotrexate sodium, a cornerstone in chemotherapy and immunosuppressive therapy.\u003cbr\u003e\u003cstrong\u003ePackaging: \u003c\/strong\u003eSupplied in packs containing five multi-dose vials, enabling effective storage and management for multiple dosing schedules.\u003cbr\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Used as part of combination chemotherapy regimens, it is indicated for severe, recalcitrant, disabling psoriasis, rheumatoid arthritis, and certain types of cancer, including leukemia, breast cancer, and osteosarcoma.\u003cbr\u003e\u003cstrong\u003eAdministration: \u003c\/strong\u003eThe injectable form allows for precise dosing and rapid onset of action, suitable for both oncology and rheumatology therapeutic protocols.\u003cbr\u003e\u003cstrong\u003eManufacturing Excellence:\u003c\/strong\u003e Produced by Pfizer, guaranteeing stringent quality control and reliable therapeutic outcomes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMethotrexate interferes with DNA synthesis, repair, and cellular replication by inhibiting the enzyme dihydrofolate reductase. This enzyme is crucial for converting dihydrofolate to tetrahydrofolate, a carrier of one-carbon groups used in the synthesis of nucleotides thymidine and purine. As a result, methotrexate exerts cytotoxic effects on rapidly dividing cells, contributing to its effectiveness in cancer therapy and providing anti-inflammatory and immunosuppressive properties in rheumatoid arthritis and psoriasis treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression:\u003c\/strong\u003e Monitor blood counts frequently as methotrexate can cause marked bone marrow depression, leading to anemia, leukopenia, and thrombocytopenia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic and Renal Toxicity:\u003c\/strong\u003e Patients should undergo regular liver and kidney function tests due to the risk of severe hepatotoxicity and nephrotoxicity.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Nursing: \u003c\/strong\u003eContraindicated during pregnancy (Category X) and breastfeeding due to the potential for fetal harm and excretion in breast milk.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal Reactions:\u003c\/strong\u003e Could lead to serious complications such as ulcerative stomatitis, diarrhea, and gastrointestinal ulceration.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulmonary Toxicity:\u003c\/strong\u003e Watch for symptoms of pulmonary function impairment, which could indicate serious respiratory complications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCommon side effects may include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eStomatitis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDizziness\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSerious side effects requiring medical attention include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere skin reactions, possibly indicative of Stevens-Johnson syndrome or toxic epidermal necrolysis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSignificant changes in laboratory tests indicating liver or renal damage\u003cbr\u003e-ymptoms of infection due to immunosuppression, like unusual fatigue, cough, or increased temperature\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRespiratory distress symptoms such as persistent dry cough or difficulty breathing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMethotrexate Sodium Injection 25 mg\/mL by Pfizer Injectables is a vital medication in the therapeutic landscape, offering multifaceted benefits across oncology, dermatology, and rheumatology. With its robust mechanism of action backed by the reliability and quality assurance of Pfizer, healthcare providers can confidently incorporate this versatile agent into comprehensive treatment plans. Proper monitoring and adherence to safety protocols are essential to maximize its therapeutic potential and safeguard patient health.\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":12227713794120,"sku":"61703-0350-38","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Methotrexate-Sodium-Injection-50-mg-Per-2-mL-Pfize-61703-0350-38r.jpg?v=1764766009"},{"product_id":"megestrol-acetate-20-mg-tablets-by-teva","title":"Megestrol Acetate 20 mg Tablets by Teva (RX)","description":"\u003cp\u003eMegestrol Acetate 20 mg tablets are a prescription medication used to treat certain types of cancer, specifically estrogen-sensitive cancers such as breast and endometrial cancer. It works by blocking the effects of estrogen in the body, slowing or stopping the growth and spread of cancer cells. Additionally, Megestrol Acetate 20 mg tablets may also be used to treat weight loss and poor appetite in patients with HIV\/AIDS or other medical conditions\u003c\/p\u003e\n\u003cp\u003eMegestrol Acetate 20 mg Tablets by Teva is a man-made chemical similar to the female hormone progesterone. Megestrol is used to treat loss of appetite and weight loss in people with acquired immunodeficiency syndrome (AIDS). Megestrol is also used in the treatment of advanced breast cancer and endometrial cancer.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eMegestrol Acetate also is used for palliative treatment of breast and endometrial carcinoma; treatment of anorexia, cachexia, or unexplained significant weight loss in patients with AIDS.\u003c\/p\u003e\n\u003cp\u003eMegestrol (me JES trole)\u003c\/p\u003e\n\u003cp\u003eBrand: Teva Pharmaceuticals\u003cbr\u003eSize: 100 Tablets\u003cbr\u003eStrength: 20 mg\u003cbr\u003eNDC: 00555-0606-02\u003cbr\u003eUPC: 305550606024\u003c\/p\u003e\n\u003cp\u003eBuy Megestrol Acetate (Megace) Tablets online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Teva Pharmaceuticals","offers":[{"title":"Default Title","offer_id":12228146856008,"sku":"00555-0606-02","price":22.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Megestrol-Acetate-20-mg-Tablets-by-Teva.jpg?v=1600369494"},{"product_id":"cytarabine-injection-1000mg-multi-dose-bulk-vial-50-ml-rx","title":"Cytarabine Injection 1000 mg per 50 mL Multi-dose Vial  50 mL by Pfizer Injectables (RX)","description":"\u003ch4\u003eHigh-Potency \u003cstrong\u003eChemotherapy for Leukemia and Lymphoma | Hospital-Grade Multi-Dose Vial\u003c\/strong\u003e\n\u003c\/h4\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eCytarabine Injection 1000 mg per 50 mL by Pfizer Injectables\u003c\/strong\u003e is a hospital-trusted, prescription-only chemotherapy agent designed for precision dosing and broad-spectrum antineoplastic activity. Used as a cornerstone in the treatment of hematologic malignancies, this multi-dose vial delivers dependable, measurable, and cost-effective therapy for cancer centers and hospital pharmacies nationwide.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003ePrimary Indications\/Uses:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAcute Myeloid Leukemia (AML)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAcute Lymphocytic Leukemia (ALL)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChronic Myelogenous Leukemia (CML) – Blast Phase\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNon-Hodgkin’s Lymphoma (NHL)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeningeal Leukemia\/Lymphoma (CNS Prophylaxis or Treatment)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOther Physician-Guided Cancer Protocols\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Features \u0026amp; Benefits:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eConcentrated 1000 mg Cytarabine in 50 mL Multi-Dose Vial\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEssential Chemotherapy Drug\u003c\/strong\u003e for Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), and Non-Hodgkin’s Lymphoma (NHL)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, Preservative-Free Hospital-Grade Solution\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTrusted by Oncologists and Cancer Centers Worldwide\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReliable, Consistent Dosing For IV, Subcutaneous, or Intrathecal Use\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eManufactured \u0026amp; Quality-Tested by Pfizer Injectables – Industry Leaders in Oncology Care\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eWhat is Cytarabine Injection?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCytarabine\u003c\/strong\u003e (also known as Ara-C) is a high-efficacy antimetabolite chemotherapeutic used primarily for the induction and consolidation treatment of hematologic cancers. It works by disrupting DNA synthesis, effectively targeting rapidly dividing cancer cells in the bone marrow and blood.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eWho Uses Cytarabine?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCytarabine injection\u003c\/strong\u003e is prescribed for adults and pediatric oncology patients undergoing chemotherapy regimens for hematologic malignancies (blood cancers) under the direct supervision of a qualified healthcare professional. It is used in hospitals, infusion centers, and specialized oncology clinics worldwide.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eHow to Use (Administration):\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eFor Hospital and Clinical Use Only.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministered Only by Trained Medical Professionals\u003c\/strong\u003e via \u003cstrong\u003eintravenous (IV) infusion\u003c\/strong\u003e, \u003cstrong\u003esubcutaneous injection\u003c\/strong\u003e, or \u003cstrong\u003eintrathecal (spinal) injection\u003c\/strong\u003e, depending on the specific treatment protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing is individualized\u003c\/strong\u003e based on treatment phase, patient body surface area, and combination with other chemotherapy drugs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eDo not self-administer. Strictly follow institutional protocols and oncologist instructions.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eProduct Category:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCytotoxic Chemotherapy Agent\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAntimetabolite Cancer Drug\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOncology\/Antineoplastic Medication\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrescription-Only Hospital Injectable\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eImportant Safety Information – Side Effects:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Nausea, vomiting, diarrhea, mouth sores (mucositis), low blood cell counts (anemia, leukopenia, thrombocytopenia), hair loss.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e Severe bone marrow suppression (risk of infection, bleeding), neurotoxicity, liver toxicity, pulmonary toxicity, allergic reactions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Regular blood tests and oncologist follow-up are required during therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarning:\u003c\/strong\u003e Use only under strict medical supervision with regular lab and clinical monitoring. Not for use outside a hospital or supervised clinical setting.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eWhy Choose Cytarabine Injection by Pfizer Injectables?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInternational Oncology Standard:\u003c\/strong\u003e Trusted for decades in hematology-oncology practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, Stable Multi-Dose Vial:\u003c\/strong\u003e Ideal for hospital\/clinical pharmacy use.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBatch-Tested for Purity, Potency \u0026amp; Consistency\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreferred by Oncologists:\u003c\/strong\u003e Part of leading evidence-based leukemia and lymphoma protocols.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBacked by Pfizer’s Expertise in Injectable Oncology Therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePfizer Cytarabine Injection 1000 mg\/50 mL: The Gold Standard Chemotherapy for AML, ALL, CML, and Lymphoma.\u003c\/strong\u003e \u003cstrong\u003eOrder for your hospital or clinic today—trusted, reliable, and ready for critical cancer care.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39999090917448,"sku":"61703-0303-46","price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cytarabine-Injection-1000-mg-per-50-mL-Multi-dose-Vial--50-mL-by-Pfizer-Injectables-61703-0303-46.jpg?v=1767802771"},{"product_id":"vincristine-sulfate-injection-1-mg-single-dose-vial-1-ml-pfizer","title":"Vincristine Sulfate Injection 1 mg Single-dose Vial 1 mL - Pfizer","description":"\u003cp\u003eVincristine Sulfate Injection 1 mg Single-dose Vial is a powerful medication that is primarily used for the treatment of various types of cancer. It belongs to a class of drugs called vinca alkaloids and works by stopping the growth and spread of cancer cells in the body. This injection is typically given intravenously by a healthcare professional and is usually administered in combination with other chemotherapy drugs for maximum effectiveness. The benefits of Vincristine Sulfate Injection are vast, as it has been found to be effective in treating a variety of cancers such as leukemia, lymphoma, and certain types of solid tumors. Its mechanism of action allows for targeted and precise destruction of cancer cells, while sparing healthy cells, which helps to reduce the side effects often associated with chemotherapy. Vincristine Sulfate Injection is a crucial tool in the fight against cancer and has been proven to improve outcomes and survival rates in patients. With its potency and versatility, it is no wonder that Vincristine Sulfate Injection is a vital component in the treatment of many different types of cancer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of Vincristine Sulfate Injection 1 mg Single-dose Vial\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEffective against various types of cancer: Vincristine sulfate injection has been proven to be effective against different types of cancer, such as leukemia, lymphoma, and solid tumors.\u003c\/li\u003e\n\u003cli\u003eQuick and targeted action: As an intravenous medication, vincristine sulfate injection can quickly circulate in the bloodstream and reach cancer cells throughout the body, providing targeted treatment.\u003c\/li\u003e\n\u003cli\u003eIncreased survival rates: Studies have shown that vincristine sulfate injection can significantly improve survival rates in patients with certain types of cancer.\u003c\/li\u003e\n\u003cli\u003eMinimal side effects: Compared to other chemotherapy drugs, vincristine sulfate injection has fewer side effects, making it a more tolerable treatment option for patients.\u003c\/li\u003e\n\u003cli\u003eEasy to administer: The single-dose vial format of vincristine sulfate injection makes it easy for healthcare professionals to administer the medication accurately and safely.\u003c\/li\u003e\n\u003cli\u003eCost-effective: Vincristine sulfate injection is a cost-effective treatment option compared to other cancer treatments such as radiation therapy or surgery.\u003c\/li\u003e\n\u003cli\u003eWidely available: Due to its proven effectiveness, safety, and affordability, vincristine sulfate injection is widely available in hospitals and cancer treatment centers.\u003c\/li\u003e\n\u003cli\u003eCan be used in combination with other treatments: Vincristine sulfate injection can be used in combination with other chemotherapy drugs or radiation therapy to achieve better treatment outcomes.\u003c\/li\u003e\n\u003cli\u003eSuitable for pediatric patients: Vincristine sulfate injection is considered safe for use in pediatric cancer patients, making it a valuable treatment for childhood cancers.\u003c\/li\u003e\n\u003cli\u003eEasy to store and transport: The single-dose vial format of vincristine sulfate injection makes it easy to store and transport, making it a convenient choice for hospitals and healthcare facilities.\u003c\/li\u003e\n\u003cli\u003ePotential for cure: In some cases, vincristine sulfate injection has been successful in achieving complete remission and even cure in certain types of cancer.\u003c\/li\u003e\n\u003cli\u003eMay improve quality of life: For patients with advanced or incurable cancer, vincristine sulfate injection may help improve their quality of life by reducing tumor size and pain.\u003c\/li\u003e\n\u003cli\u003eCan be used in elderly patients: Vincristine sulfate injection is a suitable treatment option for elderly cancer patients who may not be able to tolerate more aggressive forms of treatment.\u003c\/li\u003e\n\u003cli\u003eHigh success rate in certain cancers: Vincristine sulfate injection has a high success rate in treating certain types of cancer, such as childhood acute lymphoblastic leukemia.\u003c\/li\u003e\n\u003cli\u003ePotential for outpatient treatment: In some cases, vincristine sulfate injection can be administered as an outpatient treatment, allowing patients to receive treatment while still maintaining their daily routines.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBuy Vincristine Sulfate Injection  online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39999099207752,"sku":"61703-0309-06","price":37.75,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Vincristine-Sulfate-Injection-1-mg-Single-dose-Vial.jpg?v=1696944992"},{"product_id":"vincristine-sulfate-injection-1-mg-single-dose-vial-2-ml-pfizer","title":"Vincristine Sulfate Injection 1 mg Single-dose Vial 2 mL by Pfizer (RX)","description":"\u003cp\u003eVincristine Sulfate Injection is a chemotherapeutic medication used primarily to treat various types of cancer, including leukemia, lymphoma, and certain types of solid tumors. It functions by inhibiting the growth of cancer cells, thereby preventing their spread in the body. As a vinca alkaloid, it is administered intravenously under medical supervision and is often part of a combination chemotherapy regimen. Due to its potent effects, Vincristine can have significant side effects, thus requiring careful monitoring during treatment.\u003c\/p\u003e\n\u003cp\u003eVincristine Sulfate Injection is a chemotherapy medication provided by Pfizer Injectables in a 1 mg single-dose vial of 2 mL solution. It is used in the treatment of various types of cancer, including leukemia, lymphoma, and other types of tumors. This injectable form is intended for intravenous administration and is typically part of a combination chemotherapy regimen.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Vincristine Sulfate\u003cbr\u003e\u003cstrong\u003eConcentration: \u003c\/strong\u003e1 mg per 2 mL vial\u003cbr\u003e\u003cstrong\u003eFormulation:\u003c\/strong\u003e Injectable solution for intravenous use\u003cbr\u003e\u003cstrong\u003eIndication:\u003c\/strong\u003e Used in the treatment of leukemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabdomyosarcoma, and other types of cancer\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Administered via intravenous injection by a healthcare professional in a clinical setting\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVincristine is a vinca alkaloid that exerts its effects by inhibiting microtubule formation in the mitotic spindle of dividing cells. This interruption in microtubule dynamics inhibits cell division, thereby leading to cell death. Its action is specific to the M phase (mitosis) of the cell cycle, making it effective against rapidly dividing cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtravasation Risk:\u003c\/strong\u003e Care must be taken to avoid extravasation during administration, as vincristine is a vesicant that can cause significant tissue damage.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuropathy:\u003c\/strong\u003e Vincristine can cause peripheral neuropathy, resulting in numbness, tingling, or pain, primarily in the hands and feet.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression: \u003c\/strong\u003eMay result in a lower count of white blood cells, red blood cells, and platelets, which could increase the risk of infection, anemia, and bleeding.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications: Patients\u003c\/strong\u003e with demyelinating form of Charcot-Marie-Tooth syndrome should not receive vincristine.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Breastfeeding:\u003c\/strong\u003e Not recommended due to potential harm to the fetus or infant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile vincristine is effective, it is associated with several potential side effects, some of which can be serious:\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eConstipation\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHair loss (alopecia)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLoss of appetite (anorexia)\u003cbr\u003e  \u003cbr\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003ePeripheral neuropathy\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSevere constipation and intestinal obstructions\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAltered mental status\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHepatotoxicity (liver damage)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSevere dehydration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eOther Considerations:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients may experience jaw pain, joint pain or muscle weakness.\u003cbr\u003eMonitoring of blood counts and liver function tests is required to watch for adverse effects.\u003cbr\u003e  \u003cbr\u003ePatients receiving Vincristine Sulfate Injection should be under the care of a healthcare professional experienced in the use of cancer chemotherapeutic agents. Any serious adverse effects should be reported to a healthcare provider immediately. Depending on tolerability and response, dose adjustments may be necessary.\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39999100485704,"sku":"61703-0309-16","price":28.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Vincristine-Sulfate-Injection-1-mg-by-Pfizer.jpg?v=1730807782"},{"product_id":"fluorouracil-topical-cream-5-40-gram","title":"Fluorouracil Cream 5% by Taro 40 gram Tube (Rx)","description":"\u003ch1\u003eFluorouracil Cream 5% (Topical)\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFluorouracil (5-FU) cream is a prescription topical antineoplastic medication used in dermatology. The “5%” means it contains 5 g of fluorouracil per 100 g of cream (i.e. 50 mg per gram). Chemically, fluorouracil is a fluorinated pyrimidine (5-fluoro-2′-deoxyuridine) that acts as an antimetabolite. In its cream form, 5-FU is mixed into a “vanishing cream” base (white petrolatum, cetyl\/stearyl alcohol, propylene glycol, parabens, etc.). It is not a simple antibiotic or steroid – it is a chemotherapy agent applied to the skin. Blood levels from topical use are generally very low, but it can still cause profound local effect.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eThe Leading Topical Treatment for Actinic Keratosis, Basal Cell Carcinoma, and Pre-Cancerous Skin Lesions\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eFluorouracil inhibits DNA (and to a lesser extent RNA) synthesis in rapidly dividing cells. Once absorbed by cells, 5-FU is converted to active metabolites that \u003cstrong\u003eblock thymidylate synthase\u003c\/strong\u003e – the enzyme needed to make thymine nucleotides. This \u003cem\u003e“thymine deficiency”\u003c\/em\u003e prevents DNA replication, leading to cell death Because cancerous and precancerous skin cells divide more rapidly than normal cells, they take up more 5-FU and are selectively destroyed. (Cells with a genetic deficiency in dihydropyrimidine dehydrogenase [DPD] – the enzyme that normally breaks down fluorouracil – can have excessive drug accumulation and severe toxicity.\u003c\/p\u003e\n\u003ch2\u003eUses\u003c\/h2\u003e\n\u003cp\u003eFluorouracil 5% cream is FDA-approved for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActinic (solar) keratoses:\u003c\/strong\u003e Treating multiple precancerous sun-damaged skin lesions on face, forearms, scalp, or other areas. It clears the patchy precancerous cells to reduce progression to skin cancer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSuperficial basal cell carcinoma:\u003c\/strong\u003e For thin, low-risk basal cell skin cancers (e.g. on the face) when surgery or other treatments are impractical. (5% strength is required for this use; lower strengths are generally for actinic keratosis.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn practice, doctors often prescribe 5% 5-FU cream for widespread AKs or superficial BCCs on visible areas. (It is applied to \u003cem\u003eall\u003c\/em\u003e affected spots, not just a single lesion.) Some dermatologists also use it off-label for other skin conditions involving abnormal cell growth (e.g. superficial squamous cell carcinoma in situ or large warts), but these are less common and beyond the official label. The official prescribing information emphasizes that the diagnosis should be confirmed before treatment, since 5-FU is only proven for those conditions.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eIndications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActinic Keratosis Treatment\u003c\/strong\u003e: Significantly reduces rough, scaly patches and lesions caused by chronic sun exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBasal Cell Carcinoma Therapy\u003c\/strong\u003e: Treats superficial basal cell carcinoma (when surgery is contraindicated or not preferred).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevention of Skin Cancer\u003c\/strong\u003e: Stops the progression of pre-cancerous lesions into malignant skin cancer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Sun Damage\u003c\/strong\u003e: Improves overall skin appearance by eliminating abnormal cells and promoting the growth of healthy skin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTopical Chemotherapy:\u003c\/strong\u003e Minimizes damage to healthy surrounding tissue compared to invasive procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eWhy Choose Fluorouracil Cream 5% by Taro Pharmaceuticals?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinically Proven Effectiveness:\u003c\/strong\u003e Successfully treats and removes actinic keratosis, superficial basal cell carcinoma, and rough, scaly sun spots before they progress into skin cancer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDermatologist Recommended:\u003c\/strong\u003e Gold standard in topical skin cancer therapy for decades; safe and effective with targeted action.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy At-Home Use:\u003c\/strong\u003e Convenient 40g tube allows straightforward self-application with clear instructions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-Invasive \u0026amp; Prescription-Strength:\u003c\/strong\u003e No surgery required; powerful topical formulation penetrates the skin surface to destroy abnormal and cancerous cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevents Future Skin Cancer:\u003c\/strong\u003e Essential for high-risk patients, those with extensive sun damage, or a history of recurring skin lesions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use (Application)\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eTopical application only:\u003c\/strong\u003e Fluorouracil cream is for skin use \u003cem\u003eonly\u003c\/em\u003e. Do \u003cstrong\u003enot\u003c\/strong\u003e ingest it, get it in the eyes, nose, mouth, or vagina. Follow your doctor’s instructions exactly. Typical directions (which may vary) include applying a thin layer \u003cstrong\u003eonce or twice daily\u003c\/strong\u003e to the entire affected area (not just isolated spots) until a strong inflammatory reaction develops.\u003c\/p\u003e\n\u003cp\u003eKey application steps:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eWash and thoroughly dry the skin before application. Caregivers or patients should wash hands and wear gloves while applying.\u003c\/li\u003e\n\u003cli\u003eApply a \u003cstrong\u003ethin film\u003c\/strong\u003e of cream over all the visible lesions and a margin of surrounding skin (only enough to cover, not a thick paste).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not\u003c\/strong\u003e cover the treated area with airtight bandages or plastic. Occlusive dressings are not needed and can increase absorption and irritation – only non-occlusive gauze (for cosmetic reasons) if instructed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvoid\u003c\/strong\u003e applying to open wounds, inflamed or infected skin. Do \u003cem\u003enot\u003c\/em\u003e use on eyes, eyelids, lips, nose or inside the mouth – if contact occurs, immediately rinse with water or saline.\u003c\/li\u003e\n\u003cli\u003eAfter application, wash your hands again (unless your hands are the treated area) to remove any residual cream\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eTreatment courses are usually several weeks long. For actinic keratoses, therapy often lasts 2–6 weeks; for superficial BCC, 3–12 weeks. Your doctor will tell you when to stop, which is typically when the inflamed skin has eroded (ulcerated) and new skin is forming.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eExpected Effects During Treatment\u003c\/h2\u003e\n\u003cp\u003eFluorouracil cream causes a strong local skin reaction as it works. Initially, treated skin becomes \u003cstrong\u003ered, swollen, and extremely irritated\u003c\/strong\u003e, often with burning or stinging pain and itch. As therapy continues (usually 1–3 weeks), the lesions often blister, scab over and then ulcerate into raw, oozing patches. Gradually the dead surface skin flakes off, revealing new pink skin beneath. This “chemical burn” appearance is \u003cstrong\u003enormal and expected\u003c\/strong\u003e – it means the medication is destroying the abnormal cells.\u003c\/p\u003e\n\u003cp\u003eCommon side effects include \u003cem\u003elocal\u003c\/em\u003e pain, burning, itching, dryness, scaling, peeling, crusting, and changes in skin pigment or scarring. Small broken blood vessels (telangiectasias) may appear. The treated area may feel tender for some time. Patients should be forewarned that the skin will look much worse before it gets better. If the reaction is extremely severe, or if you develop fever, ulceration beyond the treated area, or signs of infection (pus, severe swelling), contact your healthcare provider immediately.\u003c\/p\u003e\n\u003ch2\u003eImportant Precautions and Warnings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEye\/Nose\/Mouth:\u003c\/strong\u003e Avoid all contact with mucous membranes. Even Minimal contact can cause ulcers or scarring. Wear gloves and be careful not to smear cream onto normal skin or into eyes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy\/Lactation:\u003c\/strong\u003e \u003cstrong\u003eContraindicated.\u003c\/strong\u003e Fluorouracil cream can cause serious birth defects or miscarriage. Women must avoid becoming pregnant during treatment. Nursing mothers should not use or handle the cream.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDPD Enzyme Deficiency:\u003c\/strong\u003e Patients with a rare genetic deficiency in dihydropyrimidine dehydrogenase (DPD) may develop life-threatening toxicity even from topical 5-FU. Tell your doctor if you have had unusual reactions to 5-FU or related drugs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSun Exposure:\u003c\/strong\u003e Treated skin is extremely photosensitive. While on therapy (and for about 4 weeks after), avoid direct sunlight or tanning beds. Sunburn can be severe. Wear broad-spectrum sunscreen (SPF 30+) and protective clothing outdoors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergies:\u003c\/strong\u003e Do not use if you have a known hypersensitivity to fluorouracil or any cream component (e.g. parabens, cetyl alcohol, etc.).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAge\/Other Use:\u003c\/strong\u003e Not approved for children. Use with caution in elderly or immunocompromised patients (they may react more strongly).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHandling and Storage\u003c\/h2\u003e\n\u003cp\u003eStore fluorouracil cream at room temperature (about 20–25 °C), away from moisture and heat. Do not refrigerate or freeze. Keep the tube tightly closed when not in use and out of reach of children and pets. (Accidental ingestion by pets can be fatal.) Dispose of any unused cream or applicators according to local regulations – do not pour large amounts down the drain.\u003c\/p\u003e\n\u003ch2\u003eBrand Names and Formulations\u003c\/h2\u003e\n\u003cp\u003eIn the U.S., fluorouracil cream is marketed under names like \u003cstrong\u003eEfudex, Carac, Fluoroplex, Tolak, and others\u003c\/strong\u003e. The 5% cream is the standard strength; there are also formulations at 0.5%, 1%, or 4% for different uses (e.g. very thin or sensitive areas). The product is prescription-only.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSummary:\u003c\/strong\u003e Fluorouracil 5% cream is a potent topical chemotherapy used for treating precancerous and certain superficial cancerous skin lesions. It works by blocking DNA production in rapidly dividing cells). Proper use produces a strong inflammatory reaction on the skin, which is the intended effect (the “bad reaction” indicates the drug is working). Patients must follow exact application instructions, expect intense local irritation, and observe all safety precautions (wear gloves, avoid pregnancy and sun, etc.) during treatment. With careful use under medical supervision, fluorouracil cream effectively clears many actinic keratoses and superficial skin cancers, but it must be handled as a serious medication.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eProduct Details\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Fluorouracil 5% (50mg\/g)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSize:\u003c\/strong\u003e 40 gram tube\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Taro Pharmaceuticals\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUsage:\u003c\/strong\u003e Topical, prescription only\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Treatment of actinic keratosis, superficial basal cell carcinoma, and sun-damaged skin lesions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAchieve dermatologist-recommended results with Fluorouracil Cream 5% from Taro Pharmaceuticals, the gold standard in topical chemotherapy for actinic keratosis (AK), superficial basal cell carcinoma, and other pre-cancerous and cancerous skin conditions. Trusted by skin care professionals and oncologists, this FDA-approved topical treatment helps prevent the progression of sun-damaged skin cells by targeting abnormal growths at the source.\u003c\/p\u003e","brand":"Taro Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40085290483784,"sku":"51672-4118-06","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Fluorouracil-Cream-5_-by-Taro.jpg?v=1778780627"},{"product_id":"vinorelbine-tartrate-injection-10-mg-ml-single-dose-vial-preservative-free-1-ml-rx","title":"Vinorelbine Tartrate Injection 10 mg \/ mL Single-Dose Vial, Preservative Free 1 mL Rx) *Refrigerated Item*","description":"\u003cp\u003eVinorelbine Tartrate Injection is a medication used to treat certain types of cancer, including lung cancer and breast cancer. It is a chemotherapy drug that works by stopping the growth and spread of cancer cells in the body. The 10 mg\/mL single-dose vial is a specific form and strength of this medication, meaning each mL of the solution contains 10 mg of vinorelbine tartrate. It is also preservative-free, meaning it does not contain any additional chemicals or substances that could potentially cause an allergic reaction or other adverse effects. The vial is intended for one-time use only, with the entire contents being administered to the patient in one dose. It is important to follow the specific dosing and administration instructions provided by a healthcare professional when using this medication.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e* Refrigerated Item * Must ship Next Day Air *\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVinorelbine tartrate is an anticancer medication that belongs to a class of drugs known as vinca alkaloids. It is used to treat certain types of cancer, such as non-small cell lung cancer and breast cancer. It works by preventing the growth and spread of cancer cells in the body. Vinorelbine tartrate may be given alone or in combination with other medications as part of a chemotherapy regimen. It is typically given by injection into a vein. Common side effects include nausea, vomiting,\u003c\/p\u003e","brand":"Sagent Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40279544135752,"sku":"25021-0204-01","price":48.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Vinorelbine-Tartrate-Injection-10-mg.jpg?v=1716314986"},{"product_id":"gemcitabine-injection-200gm-single-dose-vial-5-26-ml-rx","title":"Gemcitabine injection 200 mg Single Dose Vial 5.26 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection 200mg Single Dose Vial 5.26 mL is a prescription medication manufactured by Meitheal Pharmaceuticals. It contains the active ingredient gemcitabine, which belongs to a class of drugs known as antineoplastic agents. It is used to treat certain types of cancer, including breast, lung, and pancreatic cancer. The vial contains 200gm (grams) of gemcitabine in a single dose, which is equivalent to 5.26 mL (milliliters) of solution. The vial is intended for single use only and should be administered by a healthcare professional. Gemcitabine injection works by slowing or stopping the growth of cancer cells. It may also be used in combination with other medications as directed by a doctor.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits for Gemcitabine injection 200mg?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e1) Treatment of Cancer: Gemcitabine injection is primarily used in the treatment of various types of cancer, including non-small cell lung cancer, breast cancer, pancreatic cancer, and bladder cancer.\u003c\/p\u003e\n\u003cp\u003e2) Improved survival rates: Studies have shown that gemcitabine injection can significantly improve the survival rates of cancer patients, especially when used in combination with other chemotherapy drugs.\u003c\/p\u003e\n\u003cp\u003e3) Quick-acting: Gemcitabine injection has a quick onset of action, with effects seen within a few days after administration. This is important for patients who require immediate treatment for their condition.\u003c\/p\u003e\n\u003cp\u003e4) Well-tolerated: Gemcitabine injection is generally well-tolerated by patients, with minimal side effects such as nausea, vomiting, and hair loss. This makes it a suitable option for patients who may not be able to tolerate other types of chemotherapy drugs.\u003c\/p\u003e\n\u003cp\u003e5) Single Dose Convenience: Gemcitabine injection is available in a single-dose vial, making it easy for healthcare providers to administer the exact amount of medication needed without any leftover wastage.\u003c\/p\u003e\n\u003cp\u003e6) Cost-effective: As compared to other chemotherapy drugs, gemcitabine injection is relatively cost-effective, making it a viable option for patients who may have financial constraints.\u003c\/p\u003e\n\u003cp\u003e7) Can be used in combination with other drugs: Gemcitabine injection can be used in combination with other chemotherapy drugs to create a more effective treatment plan for cancer patients. \u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293412667464,"sku":"71288-0117-06","price":12.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-200gm-Single-Dose-Vial-5.26-mL.jpg?v=1716907671"},{"product_id":"gemcitabine-injection-200mg-single-dose-glass-vial-10-ml-rx","title":"Gemcitabine injection 200 mg Single Dose Glass Vial 10 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection 200mg Single Dose Glass Vial 10 mL is a prescription medication used for the treatment of various types of cancer, including breast, lung, pancreatic, ovarian, and bladder cancer. It contains 200mg of gemcitabine in a single-dose glass vial of 10 mL. Gemcitabine is a chemotherapy drug that works by interfering with the growth and spread of cancer cells in the body. It is typically administered through a vein by a healthcare professional. This specific dose and packaging may vary depending on the individual's medical condition and treatment plan.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat are Antimetabolites?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntimetabolites are molecules that resemble naturally occurring metabolites and disrupt metabolic processes within cells. They can act as competitive inhibitors of key enzymes involved in cellular metabolism, effectively blocking the normal function of these enzymes. This disruption can lead to the inhibition of cell growth and replication, making antimetabolites useful as chemotherapy agents for treating cancer. Some examples of antimetabolites include methotrexate, 5-fluorouracil, and gemcitabine.\u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293413978184,"sku":"71288-0113-10","price":12.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-200mg-Single-Dose-Glass-Vial-10-mL.jpg?v=1716908411"},{"product_id":"gemcitabine-injection-1-gram-single-dose-glass-vial-50-ml-rx","title":"Gemcitabine injection 1 gram Single Dose Glass Vial 50 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection is a chemotherapy medication used to treat certain types of cancer, such as lung, breast, ovarian, and pancreatic cancer. It is available in a single dose glass vial containing 1 gram (1000 milligrams) of the medication in 50 mL of liquid. This form of the medication is administered intravenously (through a vein) by a healthcare professional. It works by stopping the growth and spread of cancer cells in the body. \u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGemcitabine injection is a chemotherapy drug that works by interfering with the growth and reproduction of cancer cells. It is a type of antimetabolite that disrupts the synthesis of nucleic acids, which are essential for cellular division and replication. As a result, cancer cells are unable to grow and spread, ultimately leading to their death. Gemcitabine is commonly used to treat various types of cancer, including pancreatic, lung, breast, and ovarian cancer. It may also be used in combination with other chemotherapy drugs to improve its effectiveness.\u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293462376520,"sku":"71288-0114-50","price":59.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-1-gram-Single-Dose-Glass-Vial-50-mL.jpg?v=1716911123"},{"product_id":"duraclon-clonidine-hcl-for-injection-100-mcg-ml-preservative-free-10-ml-rx","title":"Duraclon Clonidine HCl Injection 100 mcg Per mL Preservative Free 10 mL (RX)","description":"\u003cp\u003eDuraclon (Clonidine HCl Injection) 100 mcg is used primarily for the management of severe pain in cancer patients. Administered epidurally, it acts as an adjunct to opioid therapy, enhancing pain relief while potentially reducing the necessary dosage of opioids. Clonidine works by activating alpha-2 adrenergic receptors, which helps modulate the perception of pain. It is used in clinical settings under careful medical supervision to ensure effective pain management and monitor side effects.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDiscover the targeted efficacy of Duraclon, a clonidine hydrochloride injection designed for precise management of severe pain in cancer patients who do not respond adequately to opioid therapy alone. Duraclon offers healthcare professionals a supplementary tool, designed for epidural infusion, providing pain relief with a unique pharmacological profile that augments analgesia.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Name:\u003c\/strong\u003e Duraclon (Clonidine Hydrochloride) Injection\u003cbr\u003e\u003cstrong\u003eConcentration: \u003c\/strong\u003e100 mcg\/mL\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Mylan Institutional\u003cbr\u003e\u003cstrong\u003eDosage Form:\u003c\/strong\u003e Sterile liquid for epidural infusion\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Provided in securely sealed vials, ensuring sterility and integrity\u003cbr\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Specifically tailored as an adjuvant for the treatment of severe pain in cancer patients, in combination with opioids.\u003cbr\u003e\u003cstrong\u003eStorage Conditions:\u003c\/strong\u003e Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Protect from light to maintain efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFeatures\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEnhanced Pain Management:\u003c\/strong\u003e Acts as a potent adjuvant to heighten the analgesic effects of opioids.\u003cbr\u003e\u003cstrong\u003eEpidural Delivery:\u003c\/strong\u003e Direct, local administration improves the targeted action to optimize patient comfort.\u003cbr\u003e\u003cstrong\u003eQuality Manufacture:\u003c\/strong\u003e Produced by Mylan Institutional, assuring consistency, safety, and reliability.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuraclon contains clonidine, an alpha-2 adrenergic agonist. It works primarily through the stimulation of alpha-2 receptors in the dorsal horn of the spinal cord, which reduces the sympathetic outflow, resulting in decreased nociceptive neurotransmitter release and hyperpolarization of pain-conducting neurons. This modulation of pain signals provides effective analgesic properties when used epidurally, especially when synergistically combined with opioids.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Administration Method:\u003c\/strong\u003e Intended strictly for epidural infusion. Ensure proper aseptic technique during handling.\u003cbr\u003e\u003cstrong\u003e2. Dilution and Dosage\u003c\/strong\u003e: Dilute with an appropriate epidural infusion solution to achieve a dose-specific combination, as per the detailed instruction of the healthcare provider. Usually administered at a rate specific to patient needs, often requiring careful titration.\u003cbr\u003e\u003cstrong\u003e3. Monitoring:\u003c\/strong\u003e Close monitoring of the patient's blood pressure and other vitals is essential during administration.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppropriate Use:\u003c\/strong\u003e Not recommended for obstetrical, postpartum, or perioperative pain management due to potential hypotension and bradycardia risks.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHemodynamic Stability: \u003c\/strong\u003eMay cause significant hypotension; therefore, use with intense caution in patients with severe cardiovascular disorders.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCNS Depressants: \u003c\/strong\u003eCoadministration with CNS depressants requires cautious titration and monitoring due to potential potentiation of effects.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWithdrawal Concerns:\u003c\/strong\u003e Abrupt discontinuation may induce rebound hypertension; discontinue therapy under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile Duraclon is generally well-managed under medical supervision, potential side effects include:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular:\u003c\/strong\u003e Hypotension, bradycardia, and possible orthostatic events.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCentral Nervous:\u003c\/strong\u003e Sedation, dizziness, headache, dry mouth.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Site Reactions\u003c\/strong\u003e: Potential localized reactions due to epidural administration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach patient's response can differ; hence, healthcare providers should tailor treatment plans with these considerations in mind. The intent is always to balance effective pain management with minimizing adverse effects.\u003c\/p\u003e\n\u003cp\u003eUsing Duraclon (Clonidine HCl) Injection from Mylan Institutional can play a crucial role in providing comprehensive, effective pain relief for eligible patients, enhancing quality of life and patient care outcomes.\u003c\/p\u003e","brand":"Mylan Institutional","offers":[{"title":"Default Title","offer_id":40350252761160,"sku":"67457-0218-10","price":47.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Duraclon-Clonidine-HCl-for-Injection-100-mcg.jpg?v=1720619281"},{"product_id":"dexamethasone-sodium-phosphate-4-mg-for-injection-single-dose-vials-1-ml-x-25-pack-rx","title":"Dexamethasone Sodium Phosphate 4 mg Injection Single Dose Vials 1 mL x 25\/Pack (Rx)","description":"\u003ch4\u003e\u003cstrong\u003e#1 Hospital-Grade Steroid Injection for Inflammation, Allergic Reactions \u0026amp; Severe Conditions\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003eDexamethasone Sodium Phosphate Injection 4 mg\/mL by Mylan Institutional is the top choice for medical professionals requiring fast-acting, high-potency corticosteroid therapy in acute and emergency care settings. With 25 sterile, single-dose 1 mL vials per pack, this universal corticosteroid solution delivers unparalleled efficacy for treating \u003cstrong\u003esevere inflammation\u003c\/strong\u003e, \u003cstrong\u003eallergic reactions\u003c\/strong\u003e, \u003cstrong\u003eadrenal insufficiency\u003c\/strong\u003e, \u003cstrong\u003eshock\u003c\/strong\u003e, \u003cstrong\u003ecerebral edema\u003c\/strong\u003e, and a wide range of autoimmune and oncological indications.\u003c\/p\u003e\n\u003ch2\u003eWhat Is Dexamethasone Sodium Phosphate Injection Used For?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere Inflammatory Conditions\u003c\/strong\u003e (rheumatoid arthritis, lupus, inflammatory bowel diseases)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcute allergic\/anaphylactic reactions\u003c\/strong\u003e refractory to standard therapy\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdrenal insufficiency\/crisis\u003c\/strong\u003e and stress dosing in steroid-dependent patients\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAsthma \u0026amp; COPD exacerbations\u003c\/strong\u003e (when rapid control is needed)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCerebral edema\u003c\/strong\u003e associated with brain tumors or trauma\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer\/oncology regimens\u003c\/strong\u003e (antiemetic, tumor edema, part of chemotherapy protocols)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShock \u0026amp; septic shock\u003c\/strong\u003e (as adjunct therapy)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSevere dermatologic, hematologic, or ophthalmic conditions\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePreoperative, intraoperative, and postoperative anti-inflammatory therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eProduct Features \u0026amp; Clinical Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Potency 4 mg\/mL Steroid:\u003c\/strong\u003e Provides immediate, broad-spectrum anti-inflammatory and immunosuppressant effects\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, Preservative-Free, Single Dose Vials:\u003c\/strong\u003e Individual 1 mL vials ensure maximum sterility and dosage accuracy, minimizing contamination risk and waste\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Administration:\u003c\/strong\u003e For intravenous (IV), intramuscular (IM), and intra-articular administration when oral dosing is not possible or rapid action is required\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHospital, Emergency \u0026amp; Oncology Use:\u003c\/strong\u003e Trusted for rapid intervention in shock, acute allergic reactions, cerebral edema, severe asthma, rheumatoid\/autoimmune flares, oncology protocols, and adrenal insufficiency\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDependable Mylan Quality:\u003c\/strong\u003e Manufactured by Mylan Institutional under stringent FDA and USP standards, batch tested for safety, potency, and consistency\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient 25\/Pack:\u003c\/strong\u003e Perfect for hospitals, emergency departments, oncology suites, surgery centers, and urgent care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use (Professional Use Only)\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFor IV, IM, or intra-articular injection only.\u003c\/strong\u003e Not for subcutaneous use.\u003c\/li\u003e\n\u003cli\u003eDosage individualized by indication, patient weight\/age, severity, and response.\u003c\/li\u003e\n\u003cli\u003eAdminister under sterile conditions in a healthcare setting, following hospital or institutional protocols.\u003c\/li\u003e\n\u003cli\u003eFollow all package insert instructions and monitor patient closely for efficacy and side effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003eWhile \u003cstrong\u003edexamethasone sodium phosphate injection\u003c\/strong\u003e is highly effective, it carries potential risks. Most common:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFluid retention, swelling, or increased blood pressure\u003c\/li\u003e\n\u003cli\u003eHyperglycemia (elevated blood sugar)\u003c\/li\u003e\n\u003cli\u003eInsomnia, mood changes, agitation\u003c\/li\u003e\n\u003cli\u003eIncreased risk of infection, delayed wound healing\u003c\/li\u003e\n\u003cli\u003eStomach upset, ulcer risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious\/Rare:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere allergic reaction (anaphylaxis)\u003c\/li\u003e\n\u003cli\u003eHeart rhythm disturbances\u003c\/li\u003e\n\u003cli\u003eGI bleeding, perforation\u003c\/li\u003e\n\u003cli\u003eAdrenal suppression\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eAlways monitor patients closely. Adjust dose or discontinue if severe side effects occur.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eWarnings \u0026amp; Precautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eFor use by trained healthcare professionals only\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eUse lowest effective dose for shortest possible duration\u003c\/li\u003e\n\u003cli\u003eContraindicated in systemic fungal infections, untreated infections, and those with known hypersensitivity to dexamethasone or excipients\u003c\/li\u003e\n\u003cli\u003eMonitor for psychiatric changes, hyperglycemia, fluid\/electrolyte imbalance, GI symptoms, and secondary infections\u003c\/li\u003e\n\u003cli\u003eUse with caution in pregnancy, breastfeeding, pediatrics, or those with renal\/hepatic impairment, diabetes, peptic ulcer, or hypertension\u003c\/li\u003e\n\u003cli\u003eTaper dosing if used longer than a few days to avoid adrenal crisis\u003c\/li\u003e\n\u003cli\u003eNot for routine use in mild conditions—reserved for severe or refractory cases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Choose Dexamethasone Sodium Phosphate by Mylan Institutional?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eTrusted worldwide by physicians, hospitals, and emergency teams\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRapid, reliable anti-inflammatory action\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile single-dose vials for exact dosing and top infection control\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeets all FDA and institutional standards\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNDC: 67457-0423-12 | UPC: 367457423128 | Mylan Product #: 042312\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e25 vials per pack = efficiency for high-volume healthcare environments\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eEnsure Immediate, Effective Intervention—Order Dexamethasone Sodium Phosphate Injection 4 mg\/mL from Mylan Institutional Today!\u003c\/h3\u003e\n\u003cp\u003eUnmatched reliability for \u003cstrong\u003ehospital emergencies, rapid allergy and anaphylaxis management, acute inflammation, oncological support, and adrenal crisis intervention\u003c\/strong\u003e—your essential hospital steroid solution.\u003c\/p\u003e","brand":"Mylan Institutional","offers":[{"title":"Default Title","offer_id":40350553800776,"sku":"67457-0423-12","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dexamethasone-Sodium-Phosphate-4-mg-Injection.jpg?v=1767634324"},{"product_id":"presnisone-tablets-5-mg-by-cadista-100-count-rx","title":"Prednisone Tablets 5 mg by Cadista 100 Count (RX)","description":"\u003cp\u003ePrednisone tablets 5 mg are a type of glucocorticoid medication that is used to treat a variety of conditions, including inflammation, allergies, and autoimmune disorders. It works by reducing the body's immune response to certain stimuli, thereby reducing inflammation and reducing the symptoms associated with these conditions. Prednisone tablets are available in different strengths, with 5 mg being a lower dose version. They are usually taken orally and can be used for short-term or long-term treatment, depending on the condition being treated.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action for Prednisone Tablets 5 mg:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePrednisone tablets 5 mg contain the active ingredient prednisone, which is a synthetic corticosteroid. The mechanism of action for prednisone is complex and involves multiple pathways in the body.\u003c\/p\u003e\n\u003cp\u003eWhen taken orally, the tablet is absorbed into the bloodstream and distributed throughout the body. In the liver, prednisone is converted into its active form, prednisolone. Prednisolone then enters the cells of various tissues and binds to glucocorticoid receptors, which are present in most cells of the body.\u003c\/p\u003e\n\u003cp\u003eOnce bound to the glucocorticoid receptors, prednisolone affects the expression of genes, leading to changes in the production of proteins. This results in a wide range of effects in the body, including:\u003c\/p\u003e\n\u003cp\u003e1. Anti-inflammatory effects: Prednisone suppresses the production of cytokines and mediators of inflammation, which are responsible for causing the symptoms of inflammation such as redness, swelling, and pain.\u003c\/p\u003e\n\u003cp\u003e2. Immunosuppressive effects: Prednisone inhibits the function of immune cells, including white blood cells, which play a key role in the body's defense against infection and disease.\u003c\/p\u003e\n\u003cp\u003e3. Anti-allergic effects: Prednisone reduces the production of immune chemicals that trigger allergic reactions, such as histamine, leading to a decrease in allergy symptoms.\u003c\/p\u003e\n\u003cp\u003e4. Metabolic effects: Prednisone can cause an increase in blood sugar levels, as well as changes in the metabolism of protein, fat, and carbohydrates.\u003c\/p\u003e\n\u003cp\u003eOverall, the mechanism of action of prednisone tablets 5 mg is to decrease inflammation, suppress the immune system, and provide relief from a variety of diseases and conditions.\u003cbr\u003e\u003c\/p\u003e","brand":"Cadista Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40362900619336,"sku":"59746-0172-06","price":34.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Presnisone-Tablets-5-mg-by-Cadista-NDC-59746-0172-06.jpg?v=1721828256"},{"product_id":"dexamethasone-sodium-phosphate-1-ml-for-injection-25-pack-rx-copy","title":"Dexamethasone Sodium Phosphate 1 mL for Injection EACH (Rx)","description":"\u003cp\u003eDexamethasone Sodium Phosphate is a synthetic glucocorticoid drug. It is used as an anti-inflammatory and immunosuppressive agent. Dexamethasone Sodium Phosphate inhibits the production of inflammatory mediators and cytokines. It also suppresses the activity of lymphocytes and macrophages. Dexamethasone Sodium Phosphate is used to treat a variety of diseases and conditions, including rheumatoid arthritis, asthma, and Crohn's disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInstructions on How to Use Dexamethasone Injection:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1. Before using this product, read the accompanying medication guide and all other information provided by your doctor or pharmacist.\u003cbr data-mce-fragment=\"1\"\u003e2. Verify the correct dose of medicine by checking the syringe before use.\u003cbr data-mce-fragment=\"1\"\u003e3. Administer the injection intramuscularly or as directed by your doctor.\u003cbr data-mce-fragment=\"1\"\u003e4. Clean the injection area with an alcohol pad before injection and allow it to dry.\u003cbr data-mce-fragment=\"1\"\u003e5. Remove the syringe needle cap and draw the required dose of Dexamethasone Sodium Phosphate Injection.\u003cbr data-mce-fragment=\"1\"\u003e6. Insert the needle into the injection site.\u003cbr data-mce-fragment=\"1\"\u003e7. Push the plunger lightly and slowly until all of the medicine is injected.\u003cbr data-mce-fragment=\"1\"\u003e8. Remove the needle from the injection site and cover it with a sterile bandage.\u003cbr data-mce-fragment=\"1\"\u003e9. Dispose of the Dexamethasone Sodium Phosphate Injection syringe and needle properly.\u003cbr data-mce-fragment=\"1\"\u003e10. Monitor your progress at regular visits and inform your doctor of any changes in your condition.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eDexamethasone Sodium Phosphate 1 mL for Injection by Hikma is used to treat various conditions such as severe allergic reactions, arthritis, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, and skin diseases. It is also used to test for an adrenal gland disorder (Cushing's syndrome). It decreases your body's natural defensive response and reduces symptoms such as swelling and allergic-type reactions.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eDexamethasone Sodium Phosphate for Injection is a corticosteroid that is used to treat a wide variety of conditions. It is a potent anti-inflammatory agent that is effective in the treatment of a wide range of diseases. Dexamethasone Sodium Phosphate for Injection is also a powerful immunosuppressant that is used to prevent the rejection of transplanted organs.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eDexamethasone is a corticosteroid hormone (glucocorticoid). This injectable form of dexamethasone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of dexamethasone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eBrand: West Ward Pharmaceutical\u003cbr data-mce-fragment=\"1\"\u003eSize: 1 mL\u003cbr data-mce-fragment=\"1\"\u003eNDC: 00641-0367-25\u003cbr data-mce-fragment=\"1\"\u003eUPC: 306410367253\u003cbr\u003e\u003c\/p\u003e","brand":"Hikma","offers":[{"title":"Default Title","offer_id":40366700724296,"sku":"00641-0367-25ea","price":6.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dexamethasone-Sodium-Phosphate-1-mL-by-Hikma-NDC-00641-0367-25.jpg?v=1748525091"},{"product_id":"cisplatin-injection-100-mg-100-ml-1-mg-ml-preservative-free-multiple-use-vial-100-ml-rx","title":"Cisplatin Injection 100 mg\/100 mL (1 mg\/mL) Preservative Free Multiple Use Vial 100 mL (RX)","description":"\u003cp\u003eCisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a prescription medication that is commonly used as a chemotherapy drug. It is a colorless liquid that is administered into the vein by a healthcare professional. Each vial contains 100 mg of cisplatin in 100 mL of solution, resulting in a concentration of 1 mg\/mL. The vial does not contain any preservatives and can be used for multiple doses, as directed by a doctor. This medication works by damaging the DNA of cancer cells, which helps to slow or stop their growth and reproduction. It may be used to treat a variety of cancers, such as ovarian cancer, lung cancer, or testicular cancer. It is important to follow all dosage and safety instructions provided by a doctor while using this medication.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does it Work?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a chemotherapy medication used to treat various types of cancer, such as lung, ovarian, bladder, and testicular cancer. It works by damaging the DNA of cancer cells, which leads to their death.\u003c\/p\u003e\n\u003cp\u003eCisplatin belongs to a class of medications called platinum-based drugs. It contains the active ingredient cisplatin, which is a platinum compound. When cisplatin enters the body, it attaches to and damages the DNA of cancer cells, preventing them from reproducing and dividing. This ultimately leads to the death of the cancer cells.\u003c\/p\u003e\n\u003cp\u003eCisplatin also interferes with the ability of cancer cells to repair damages to their DNA. This further contributes to the destruction of cancer cells. Additionally, cisplatin can create free radicals, which cause oxidative stress and damage to the cancer cells.\u003c\/p\u003e\n\u003cp\u003eIn addition to directly killing cancer cells, cisplatin also works by preventing the formation of new blood vessels that supply nutrients to the tumors. This process is known as angiogenesis and it plays an important role in the growth and spread of tumors. By inhibiting angiogenesis, cisplatin can slow down the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp\u003eOverall, Cisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a powerful medication that works by stopping the growth and spread of cancer cells. It is often used in combination with other chemotherapy drugs to increase its effectiveness.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Accord Healthcare","offers":[{"title":"Default Title","offer_id":40373326315592,"sku":"16729-0288-38","price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cisplatin-Injection-100-mg-Multiple-Use-Vial-nDC-16729-0288-38.jpg?v=1723548837"},{"product_id":"prolia-denosumab-60-mg-ml-prefilled-syringe-injection-by-amgen-rx","title":"Prolia Denosumab 60 mg\/mL Prefilled Syringe Injection by Amgen (RX) **Requires Refrigeration**","description":"\u003cp\u003eProlia® (denosumab) is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.\u003c\/p\u003e\n\u003cp\u003eProlia (denosumab) 60 mg\/mL is a prescription medication manufactured by Amgen, available in a prefilled syringe for subcutaneous injection. This biologic agent is primarily used to treat osteoporosis in postmenopausal women and men at high risk for fractures. It works by inhibiting a specific protein involved in bone resorption, ultimately improving bone density and reducing the likelihood of fractures.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Denosumab\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e  60 mg\/mL per prefilled syringe\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdministration: Subcutaneous injection, typically administered once every six months\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand:\u003c\/strong\u003e Prolia®\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer\u003c\/strong\u003e: Amgen Inc\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eApplication:\u003c\/strong\u003e Bone Resorption Inhibitor\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContainer Type: \u003c\/strong\u003ePrefilled Syringe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e Injection\u003c\/li\u003e\n\u003cli\u003ePreservative Free\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC Number\u003c\/strong\u003e: 55513-0710-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUPC: \u003c\/strong\u003e355513710015\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage Requirements\u003c\/strong\u003e: Requires Refrigeration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTreatment of osteoporosis in postmenopausal women at high risk for fracture.\u003c\/li\u003e\n\u003cli\u003eIncrease in bone mass in men with osteoporosis at high risk for fracture.\u003c\/li\u003e\n\u003cli\u003eTreatment of bone loss in men receiving androgen deprivation therapy for prostate cancer.\u003c\/li\u003e\n\u003cli\u003eTreatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDenosumab is a monoclonal antibody that targets and binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand), a protein essential for the formation, function, and survival of osteoclasts (cells responsible for bone resorption). By inhibiting RANKL, Prolia effectively decreases the breakdown of bone, leading to increased bone mass and strength.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration Instructions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdministered by a healthcare professional or with proper training for self-administration\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eInjection site should be the upper arm, upper thigh, or abdomen\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFollow proper sterilization techniques to minimize the risk of infection\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include back pain, musculoskeletal pain, elevated cholesterol levels, and urinary tract infections. Serious adverse reactions could involve hypocalcemia (low blood calcium levels), serious infections, dermatologic reactions, and osteonecrosis of the jaw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStore in a refrigerator between 2°C to 8°C (36°F to 46°F)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDo not freeze\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eProtect from light\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKeep the syringe in the outer carton until ready for use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eContraindications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eHypersensitivity to denosumab or any inactive ingredient in Prolia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePatients with hypocalcemia must have their condition corrected before receiving Prolia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEnsure adequate intake of calcium and vitamin D to mitigate the risk of hypocalcemia\u003c\/li\u003e\n\u003cli\u003eRegular monitoring of calcium levels, especially in individuals at risk\u003c\/li\u003e\n\u003cli\u003eInform your healthcare provider of any medical conditions, including existing dental problems or upcoming dental procedures\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProlia represents an important advancement in the management of osteoporosis and other related conditions, offering a significant improvement in patient outcomes through its targeted approach to bone preservation.\u003cbr\u003e\u003c\/p\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":40388475682888,"sku":"55513-0710-01","price":2450.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prolia-Denosumab-60-mg_mL-Prefilled-Syringe-Injection-by-Amgen.jpg?v=1725886109"},{"product_id":"zoledronic-acid-injection-4-mg-5-ml-0-8-mg-ml-single-dose-viial-5-ml-by-avet-pharmaceuticals-rx","title":"Zoledronic Acid Injection 4 mg\/ 5 mL (0.8 mg\/mL) Single-Dose Viial 5 mL (RX)","description":"\u003cp\u003eZoledronic Acid Injection is used to treat various bone-related conditions. It is commonly prescribed to manage osteoporosis in postmenopausal women and men, reducing the risk of fractures. It also treats Paget's disease of bone and lowers high blood calcium levels (hypercalcemia) associated with cancer. As a bisphosphonate, zoledronic acid works by inhibiting bone resorption, thus strengthening bones and decreasing bone pain. It is typically administered intravenously by healthcare professionals, ensuring appropriate dosage and patient monitoring.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpecifications: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: Zoledronic Acid\u003cbr\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e: 0.8 mg\/mL\u003cbr\u003e\u003cstrong\u003eVolume:\u003c\/strong\u003e 5 mL per vial\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial\u003cbr\u003e\u003cstrong\u003eBrand:\u003c\/strong\u003e Avet Pharmaceuticals\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003eIntravenous injection\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration and Formulation:\u003c\/strong\u003e Each vial contains 4 mg of zoledronic acid in a 5 mL solution (0.8 mg\/mL).\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial provides exact dosage for individual treatments.\u003cbr\u003e\u003cstrong\u003eApplications:\u003c\/strong\u003e Effective in treating osteoporosis, Paget's disease of bone, and managing hypercalcemia due to cancer.\u003cbr\u003e\u003cstrong\u003eQuality and Efficacy:\u003c\/strong\u003e Known for its therapeutic reliability, manufactured under strict quality control criteria.\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Designed for intravenous infusion under the supervision of a qualified healthcare provider.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eZoledronic acid is a bisphosphonate, a class of drugs that inhibit osteoclast-mediated bone resorption. By binding to bone mineral, zoledronic acid disrupts the osteoclast activity, leading to decreased bone breakdown and turnover. The net effect is an increase in bone mineral density, reducing the risk of fractures in osteoporosis and slowing the progression of bone damage in other related conditions. Additionally, by lowering serum calcium levels, it effectively treats hypercalcemia associated with malignancy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Preparation:\u003c\/strong\u003e Ensure that the patient is well-hydrated before administering the drug to minimize the risk of renal adverse effects.\u003cbr\u003e\u003cstrong\u003e2. Dosage and Administration:\u003c\/strong\u003e Administer as an intravenous infusion over no less than 15 minutes. Follow specific dosing instructions based on the condition being treated and the patient's health status.\u003cbr\u003e\u003cstrong\u003e3. Monitoring:\u003c\/strong\u003e Regularly check renal function and serum calcium levels pre-and post-administration to ensure patient safety and drug efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Cautions:\u003c\/strong\u003e Use with caution in patients with compromised renal function. Dose adjustment may be necessary.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypocalcemia:\u003c\/strong\u003e Ensure proper calcium and vitamin D supplementation prior to administration to reduce the risk of hypocalcemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity Reactions:\u003c\/strong\u003e Discontinue immediately if signs of allergic reactions or severe skin reactions occur.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Lactation:\u003c\/strong\u003e Not recommended for pregnant or lactating women unless clearly needed and prescribed by a healthcare professional.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile the medication is generally well-tolerated, some patients may experience side effects, including:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Fever, fatigue, musculoskeletal pain, and flu-like symptoms.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious Side Effects: \u003c\/strong\u003eRenal impairment, acute phase reactions, hypocalcemia, and in rare cases, osteonecrosis of the jaw.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring Required:\u003c\/strong\u003e Close observation for any adverse effects, particularly in individuals with pre-existing conditions that affect renal or bone health.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eZoledronic Acid Injection 4 mg\/5 mL by [Manufacturer Name] represents a crucial intervention for managing bone-catastrophic conditions, ensuring that patients receive informed, safe, and effective treatment aimed at preserving bone integrity and overall physical health. Always consult and adhere to healthcare professional guidance when administering this medication.\u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40388509368392,"sku":"23155-0170-31","price":43.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Zoledronic-Acid-Injection-4-mg-by-Avet-Pharmaceuticals_038bd6a0-5d1d-4f67-a402-cd13e35395cc.jpg?v=1731424616"},{"product_id":"prednisone-tablets-2-5-mg-by-endo-usa-100-count-rx","title":"Prednisone Tablets 2.5 mg by Endo USA 100 Count (RX)","description":"\u003cp\u003ePrednisone Tablets 2.5 mg are used to treat various inflammatory and autoimmune conditions by suppressing the immune system. They are effective in managing allergic reactions, asthma, rheumatoid arthritis, lupus, and skin disorders. Prednisone helps reduce inflammation, pain, and swelling, providing relief from symptoms. It is also used in certain cancer treatments and to prevent organ rejection in transplants. The dosage and duration depend on the specific condition and patient response, and it is typically used under strict medical supervision.\u003c\/p\u003e\n\u003cp\u003ePrednisone Tablets 2.5 mg by Endo Pharmaceuticals is a highly effective corticosteroid designed to manage a variety of inflammatory and autoimmune conditions. Whether for acute or chronic treatment, these tablets provide relief by reducing inflammation and modulating immune response, making them indispensable in the therapeutic arsenal for conditions such as arthritis, allergies, asthma, and certain skin disorders. Packaged in a convenient 100-count bottle, Prednisone by Endo assures both value and quality for consistent patient care.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage Strength:\u003c\/strong\u003e Each tablet contains 2.5 mg of prednisone.\u003cbr\u003e\u003cstrong\u003eCount: \u003c\/strong\u003e100 tablets per bottle, ensuring an adequate supply for extended treatment courses.\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Endo Pharmaceuticals, known for delivering high-quality and reliable pharmaceutical products.\u003cbr\u003e\u003cstrong\u003eIndications: \u003c\/strong\u003eUsed for managing inflammatory and autoimmune diseases including rheumatoid arthritis, lupus, asthma, allergies, multiple sclerosis, and as an adjunctive therapy in certain cancer treatments.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePrednisone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by inhibiting leukocyte infiltration at the site of inflammation, interfering with mediators of inflammatory response, and suppressing humoral immune responses. It achieves this by altering the transcription of inflammatory and immune-related genes, leading to a decrease in the production of pro-inflammatory cytokines and chemical mediators.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe prescribed dosage varies widely based on the medical condition, patient response, and corresponding medical protocols. Typically, the healthcare provider sets the exact daily or alternate day regimen tailored to the individual needs of the patient.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdminister orally with a full glass of water, preferably with food or milk to minimize gastrointestinal upset.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGradual dosage adjustment is recommended under professional supervision to prevent withdrawal symptoms in long-term usage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProlonged use may lead to steroid-related side effects such as adrenal suppression; hence abrupt discontinuation should be avoided.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePatients with systemic fungal infections should not use prednisone; contraindicated for individuals with known hypersensitivity to the drug.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eUse with caution in individuals with conditions such as diabetes, hypertension, osteoporosis, and peptic ulcer disease.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMay mask signs of infection and lead to new infections due to immune system suppression.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePregnant or nursing women should only use prednisone if clearly needed and under professional guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile prednisone effectively reduces inflammation, it may produce side effects, particularly with long-term use, including:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Increased appetite, weight gain, insomnia, mood swings, acne, dry skin, increased sweating.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious:\u003c\/strong\u003e Hypertension, high blood sugar levels, Cushing's syndrome, increased risk of infections, osteoporosis, adrenal insufficiency upon withdrawal, peptic ulcers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePrednisone Tablets 2.5 mg by Endo provides a robust solution for managing a spectrum of inflammatory and autoimmune disorders. Its proven efficacy in reducing inflammation and modulating immune responses contributes significantly to patient management in both acute and chronic settings. As with all steroids, judicious use is essential to minimize side effects and optimize therapeutic outcomes, under the vigilant guidance of a healthcare professional.\u003c\/p\u003e","brand":"Endo","offers":[{"title":"Default Title","offer_id":51707168489840,"sku":"00603-5336-21","price":11.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prednisone-Tablets-2.5-mg-by-Endo_c757a786-1e5e-4676-8909-5c09336b577f.jpg?v=1748455221"},{"product_id":"cyclophosphamide-for-injection-500-mg","title":"Cyclophosphamide Injection 500 mg Single-Dose Vial (RX)","description":"\u003ch1\u003eCyclophosphamide Injection 500 mg – Alkylating Chemotherapy\/Immunosuppressant\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eCyclophosphamide\u003c\/strong\u003e is a potent alkylating agent (nitrogen mustard derivative) used in oncology and severe autoimmune diseases. The 500 mg injection is supplied as a sterile lyophilized powder (200 mg\/mL concentrate when reconstituted). It is a \u003cstrong\u003eprodrug\u003c\/strong\u003e that requires activation in the liver: cytochrome P450 enzymes convert cyclophosphamide to active metabolites (primarily 4-hydroxycyclophosphamide\/aldophosphamide), which then degrade to \u003cstrong\u003ephosphoramide mustard\u003c\/strong\u003e (the DNA-alkylating moiety) and acrolein. Phosphoramide mustard forms covalent intra- and inter-strand DNA crosslinks (especially at guanine N7) that block DNA replication and transcription, triggering tumor cell apoptosis. Acrolein is a toxic byproduct responsible for the drug’s urotoxicity (hemorrhagic cystitis) \u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eUses and Indications\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide injection is indicated for various \u003cstrong\u003emalignancies\u003c\/strong\u003e as part of combination chemotherapy regimens. It is active against many hematologic and solid tumors, including Hodgkin and non-Hodgkin lymphomas, multiple myeloma, chronic and acute leukemias, neuroblastoma, breast carcinoma, ovarian adenocarcinoma, retinoblastoma and others. Typical adult dosing (when used alone) is 40–50 mg\/kg IV over 2–5 days, or 10–15 mg\/kg IV every 1–2 weeks, or 3–5 mg\/kg IV twice weekly (total dose varies by protocol). In practice, cyclophosphamide is rarely given as monotherapy; more often it appears in regimens like CHOP (with doxorubicin, vincristine, prednisone), BEP (with bleomycin, etoposide), or as a conditioning agent before bone marrow transplant.\u003c\/p\u003e\n\u003ch2\u003eOff-label uses:\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide’s immunosuppressive effect (lymphocyte depletion) makes it useful in severe autoimmune disorders. Intravenous cyclophosphamide pulses are used in refractory rheumatoid arthritis, systemic lupus erythematosus (especially lupus nephritis), vasculitides (Wegener’s, microscopic polyangiitis), multiple sclerosis, and other steroid-resistant inflammatory diseases. (These indications are NOT on the FDA label and require careful risk–benefit assessment.) In rheumatology, typical pulse dosing might be 500–1000 mg IV monthly.\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFormulation:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eThe 500 mg vial contains cyclophosphamide monohydrate powder. Reconstitute per label: add sterile water for injection to the vial (e.g. 2.5 mL to yield 200 mg\/mL). Then further dilute in IV fluid to at most 2 mg\/mL (e.g. add to 250–500 mL compatible diluent). Suitable diluents include 5% dextrose or 0.9% saline. The prepared solution is light yellow and should be inspected for particulates; any sign of “melting” or particulate matter requires discarding the vial. Cyclophosphamide is a \u003cstrong\u003ehazardous drug\u003c\/strong\u003e (cytotoxic). Follow safety protocols when handling – wear gloves, eye protection, and gown; use a chemoprotected syringe\/needle, and dispose of sharps properly. Many facilities use a biological safety cabinet for compounding.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eAdministration and Nursing Technique\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute and timing:\u003c\/strong\u003e Cyclophosphamide \u003cstrong\u003emust be given IV only\u003c\/strong\u003e (never IM or subcutaneous), after dilution. There is \u003cstrong\u003eno intrathecal use\u003c\/strong\u003e – accidental intrathecal administration is fatal. Give by slow infusion: infuse 500 mg (2.5 mL reconstituted to 200 mg\/mL) over 15–30 minutes, or longer at high doses, to avoid hypotension and toxicity. (Some protocols call for infusing 1000 mg or more over 2 hours in transplant prep.) It is often given \u003cstrong\u003ein the morning\u003c\/strong\u003e to allow forced diuresis during waking hours.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHydration:\u003c\/strong\u003e Aggressive IV hydration is critical to reduce bladder toxicity. Ensure the patient drinks or receives IV fluids so that urine output remains brisk. In practice, patients are kept on continuous IV fluids (e.g. D5W or saline) during and for 24 hours after infusion. Encourage frequent voiding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAdjunctive Mesna (prevent hemorrhagic cystitis):\u003c\/strong\u003e For high-dose regimens (cumulative cyclophosphamide ≥ 60 mg\/kg, or single doses \u0026gt;1–2 g\/m^2), prophylactic \u003cstrong\u003emesna\u003c\/strong\u003e is often used. Mesna binds acrolein in the urine, preventing bladder irritation. The label notes that mesna \u003cem\u003e“has been used to prevent severe bladder toxicity”\u003c\/em\u003e. Typical mesna dosing is 20–60% of the cyclophosphamide dose, given IV at the same time and again at 4 and 8 hours.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation and labeling:\u003c\/strong\u003e Reconstituted cyclophosphamide (after adding sterile water) has limited stability. Use immediately or store refrigerated (2–8°C) for up to 8 hours. Once diluted in drip fluids, keep the solution cool and use within 24–36 hours (see Prescriber’s label for exact times). Label the infusion clearly as “Cyclophosphamide – Cytotoxic” and date\/time.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMonitoring during infusion:\u003c\/strong\u003e Check IV access patency (avoid extravasation – cyclophosphamide tissue extravasation requires immediate saline washout). Monitor vital signs; hypotension can occur if infused too rapidly. Observe patient for immediate hypersensitivity (rash, bronchospasm) – though true allergic reactions are rare, histamine release and flushing may occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePost-infusion care:\u003c\/strong\u003e Continue IV fluids post-dose for at least 12–24 hours. Encourage oral fluids and frequent voiding for the next day. Provide antiemetics prophylactically (cyclophosphamide causes moderate-to-severe nausea\/vomiting). Common choices are ondansetron or dimenhydrinate given just before and 4–6 hours after the infusion.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects and Precautions\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide’s toxicity is largely dose-related. Key adverse effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMyelosuppression (bone marrow toxicity):\u003c\/strong\u003e Cyclophosphamide can cause profound leukopenia, neutropenia, thrombocytopenia and anemia. This is dose-limiting – nadir blood counts typically occur 7–14 days post-infusion. \u003cstrong\u003eSevere immunosuppression\u003c\/strong\u003e can lead to life-threatening infections. Monitor CBC with differential \u003cstrong\u003ebefore each cycle\u003c\/strong\u003e and weekly during therapy. Do not give cyclophosphamide if marrow reserves are low (e.g. prior radiation, other chemo). Provide growth factor or transfusions if indicated. Instruct the patient to check temperature daily and report fever or signs of infection immediately.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHemorrhagic cystitis (urinary toxicity):\u003c\/strong\u003e Acrolein metabolite irritates the bladder lining, causing \u003cstrong\u003ehemorrhagic cystitis, urethritis, hematuria\u003c\/strong\u003e. This can be severe or even fatal. Preventive measures are essential: ensure adequate hydration and frequent voiding; administer mesna when indicated; check urine for occult blood after treatment. If hematuria occurs, stop cyclophosphamide and evaluate (possible bladder irrigation or cystoscopy).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal:\u003c\/strong\u003e Nausea and vomiting are common (often within hours of infusion). Use antiemetics prophylactically. Mucosal ulceration (stomatitis, esophagitis) can occur at high doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAlopecia:\u003c\/strong\u003e Hair loss is frequent and often complete; regrowth occurs weeks after stopping therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGonadal toxicity (infertility):\u003c\/strong\u003e Cyclophosphamide is highly gonadotoxic. It can cause \u003cstrong\u003eovarian failure and amenorrhea\u003c\/strong\u003e in women and \u003cstrong\u003eazoospermia\u003c\/strong\u003e in men. The risk is higher with larger cumulative doses and older age. Patients should be warned of possible permanent sterility. Discuss fertility preservation (sperm or oocyte banking) before treatment in appropriate patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSecondary malignancies:\u003c\/strong\u003e Cyclophosphamide is a known carcinogen\/genotoxic. Long-term therapy increases risk of new cancers, especially \u003cstrong\u003eurinary bladder carcinoma\u003c\/strong\u003e and hematologic malignancies (acute leukemia, myelodysplasia). (Urinary tract cancers in cyclophosphamide patients are often linked to hemorrhagic cystitis.) Always emphasize bladder protection and use the minimum effective dose.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCardiotoxicity:\u003c\/strong\u003e At very high doses, cyclophosphamide can cause acute cardiac toxicity (myocarditis, pericarditis, heart failure). This is rare at standard regimens, but warrants caution in patients with existing heart disease.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSIADH\/hyponatremia:\u003c\/strong\u003e Rarely, cyclophosphamide can cause severe dilutional hyponatremia (water retention with SIADH-like syndrome). (Ensure patients do not overconsume hypotonic fluids after infusion.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther:\u003c\/strong\u003e Interstitial pneumonitis\/pulmonary fibrosis (with extended use), skin pigmentation changes, nail changes. Cyclophosphamide can interfere with wound healing (avoid elective surgeries soon after infusion).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eContraindications and Special Considerations\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Contraindicated if patient has known allergy to cyclophosphamide (rare) (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=CONTRAINDICATIONS\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUrinary obstruction:\u003c\/strong\u003e Contraindicated in acute bladder outlet obstruction or anuria (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=Hypersensitivity%20to%20cyclophosphamide%20\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e). Always ensure good renal function and no blockages before giving.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy\/Breastfeeding:\u003c\/strong\u003e Cyclophosphamide is \u003cstrong\u003eteratogenic and abortifacient\u003c\/strong\u003e. Category D – avoid in pregnancy (women of childbearing age must use effective contraception). Use in pregnancy only for life-threatening conditions (e.g. certain cancers, lupus nephritis) and only under specialist care. It is excreted in breast milk, so breastfeeding is contraindicated during treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfertility counseling:\u003c\/strong\u003e (as above) Discuss fertility risks with both men and women prior to therapy (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=Male%20and%20female%20reproductive%20function,\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccinations:\u003c\/strong\u003e Do \u003cstrong\u003enot\u003c\/strong\u003e give live vaccines during or immediately after therapy. Patients are immunocompromised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e There are no major drug-drug interactions via cytochrome P450 inhibition noted (cyclophosphamide requires activation). However, concurrent use with other marrow-suppressants (e.g. radiation, other cytotoxics) synergistically increases neutropenia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eNursing and Clinical Tips\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation:\u003c\/strong\u003e Before use, check the vial for damage or “melted” contents (cyclophosphamide can crystallize or melt if overheated). Add diluent carefully (the powder may foam). Label the solution once prepared. Use designated cytotoxic equipment and double-glove when handling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHydration:\u003c\/strong\u003e Educate the care team to enforce IV fluids and voiding during and after infusion. (Nurse tip: Record intake\/output closely for 24 hours.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAntiemetics:\u003c\/strong\u003e Administer anti-nausea meds (ondansetron, dexamethasone) 30–60 min before infusion to improve patient comfort.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Check vital signs and observe for infusion reactions. Assess urine color and blood periodically. Draw CBC prior to each dose; post-dose, monitor counts weekly until recovery. Check renal function (BUN\/Cr) and liver enzymes periodically.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePatient education:\u003c\/strong\u003e Instruct patients about side effects: hair loss (advise head covering if desired), avoid prolonged sun exposure (photosensitivity). Emphasize reporting any fever, burning on urination, blood in urine, or unexplained bruising immediately. Reinforce strict birth control and postponing pregnancy. Advise them that immune defenses will be low – avoid crowds\/sick contacts.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHandling spills\/exposure:\u003c\/strong\u003e As a hazardous agent, any spill must be cleaned up per facility protocol (chemotherapy spill kit). If skin contact occurs, wash thoroughly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCyclophosphamide injection is a cornerstone of many treatment protocols due to its broad cytotoxic activity. However, it requires careful dosing, vigorous prevention of bladder toxicity, and close monitoring of blood counts and organ function. By following proper infusion techniques and citing the guidelines above, clinicians can maximize its therapeutic benefits while minimizing risks.\u003c\/p\u003e\n\u003ch2\u003eProduct Details and Features\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Name: \u003c\/strong\u003eCyclophosphamide for Injection\u003cbr\u003e\u003cstrong\u003eStrength: \u003c\/strong\u003e500 mg per single-dose vial\u003cbr\u003e\u003cstrong\u003eManufacturer: \u003c\/strong\u003eLong Grove\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003eSterile powder for reconstitution and intravenous or intramuscular administration\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Secure and sterile packaging to preserve potency and integrity until reconstitution\u003cbr\u003e\u003cstrong\u003eIndications: \u003c\/strong\u003ePrimarily indicated for the treatment of malignant lymphomas, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian carcinoma, and breast carcinoma. Also used in conditioning regimens prior to bone marrow transplantation and in certain autoimmune disorders.\u003cbr\u003e\u003cstrong\u003eStorage Conditions:\u003c\/strong\u003e Store vials at controlled room temperature, 20°C to 25°C (68°F to 77°F). Protect from light.\u003c\/p\u003e\n\u003ch2\u003eFeatures\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad-spectrum Usage:\u003c\/strong\u003e Effective against a variety of cancer types and suitable for autoimmune conditions.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Clinical Efficacy:\u003c\/strong\u003e Well-documented results in oncology as a monotherapy or in combination regimens.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliable Manufacturing: \u003c\/strong\u003eProduced by Long Grove, guaranteeing quality assurance in every vial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDirections for Use\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. Reconstitution: \u003c\/strong\u003eAseptically reconstitute the 500 mg powder with an appropriate volume of Sterile Water for Injection (as indicated in product literature) to ensure complete dissolution.\u003cbr\u003e\u003cstrong\u003e2. Administration: \u003c\/strong\u003eAdminister intravenously over a specified period or intramuscularly, taking care to consider the therapeutic regimen that may require dose adjustments based on patient tolerance and intended outcomes.\u003cbr\u003e\u003cstrong\u003e3. Dosage: \u003c\/strong\u003eDosage is highly individualized according to type and stage of cancer, patient size, and regimen (monotherapy or combination therapy). Medical professionals should establish protocols.\u003cbr\u003e\u003cstrong\u003e4. Supervision: \u003c\/strong\u003eTherapy should be administered under the superintendency of a qualified medical professional experienced in cancer chemotherapy.\u003c\/p\u003e\n\u003ch2\u003eWarnings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression: \u003c\/strong\u003eMonitor blood counts frequently as cyclophosphamide can induce leukopenia, thrombocytopenia, and anemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecondary Malignancies:\u003c\/strong\u003e Long-term use may risk developing secondary malignancies.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eToxicity:\u003c\/strong\u003e Risks include cardiotoxicity at high dosages, potential liver toxicity.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity Reactions:\u003c\/strong\u003e Some patients may demonstrate hypersensitivity leading to adverse reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eWhile cyclophosphamide is often tolerated given its therapeutic importance, it may cause side effects:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Nausea, vomiting, alopecia, and fatigue.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious: \u003c\/strong\u003eHemorrhagic cystitis due to acrolein (a metabolite); requires adequate hydration and possibly mesna therapy for prevention.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunosuppressive Effects:\u003c\/strong\u003e Increased risk of infection due to bone marrow suppression.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal and Dermatological: \u003c\/strong\u003eMucosal damage and skin reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCyclophosphamide for Injection is a critical component in cancer therapy, with proven effectiveness across diverse malignancies. Always consult with healthcare professionals for suitability, dosage, and monitoring to optimize therapeutic outcomes while minimizing adverse effects. Trust Cyclophosphamide by Long Grove to be a cornerstone of effective oncological care.\u003c\/p\u003e","brand":"Long Grove Pharmaceuticals","offers":[{"title":"Default Title","offer_id":51833236291952,"sku":"81298-8110-01","price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cyclophosphamide-Injection-500-mg-Long-Grove-Pharmaceuticals-81298-8110-01.jpg?v=1764791716"},{"product_id":"paclitaxel-injection-6-mg-multiple-dose-onco-tain-glass-fliptop-vial-5-ml-rx","title":"Paclitaxel Injection 6 mg Multiple Dose Onco-Tain Glass Flip-top Vial 5 mL (RX)","description":"\u003cp\u003eDiscover the benefits of Paclitaxel Injection for cancer treatment. Explore its role in chemotherapy and oncology care for better health.\u003c\/p\u003e\n\u003cp\u003ePaclitaxel Injection 6 mg multiple-dose vial is a chemotherapy medication used to treat various types of cancer, including breast, ovarian, lung, and AIDS-related Kaposi's sarcoma. It works by inhibiting cell division, effectively slowing or stopping the growth of cancer cells. This medication is typically administered in a healthcare setting under professional supervision. Side effects may include nausea, hair loss, and potential low blood cell counts. Patients should be monitored for allergic reactions and heart rate changes during treatment.\u003c\/p\u003e\n\u003cp\u003ePaclitaxel Injection 6 mg\/mL is a pivotal chemotherapy agent formulated by Pfizer Injectables, designed to combat various malignancies. Packaged in a 5 mL Multi-Dose Onco-Tain Glass Fliptop Vial, this product offers both efficacy and convenience. As a cornerstone in oncologic treatment regimens, Paclitaxel works meticulously to inhibit cancer cell proliferation, making it invaluable in the therapeutic arsenal against cancer. The Onco-Tain vial design ensures the stability and sterility of this vital medication, catering to the demanding requirements of medical professionals and patients alike.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Paclitaxel 6 mg\/mL\u003cbr\u003e\u003cstrong\u003eDosage \u003c\/strong\u003eForm: Injection\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e 5 mL Multi-Dose Onco-Tain Glass Fliptop Vial\u003cbr\u003e\u003cstrong\u003eManufacturer: \u003c\/strong\u003ePfizer Injectables\u003cbr\u003e\u003cstrong\u003eStabilized Formulation:\u003c\/strong\u003e Ensures prolonged efficacy\u003cbr\u003e\u003cstrong\u003eSecure Packaging:\u003c\/strong\u003e Designed to maintain sterility and drug integrity\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePaclitaxel functions primarily by disrupting the normal function of microtubule growth and stabilization in cell division. By promoting microtubule assembly and inhibiting their disassembly, Paclitaxel effectively halts mitosis, thereby preventing cancer cells from dividing. This disruption causes cell cycle arrest at the G2\/M phase, leading to apoptosis, or programmed cell death, in rapidly proliferating cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Administration:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePaclitaxel Injection should be administered under the supervision of a qualified oncologist experienced in chemotherapy administration.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eIntravenous administration is required, following proper dilution with an appropriate solution as recommended.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e2. Dosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe dosage is determined based on the individual patient’s body surface area, type of cancer, and specific therapy regimen.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e3. Preparation and Precautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUse protective equipment when handling the vial. \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe solution must be inspected visually for particulate matter and discoloration prior to administration. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity: \u003c\/strong\u003eSevere hypersensitivity reactions have been reported; appropriate premedication is necessary.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression:\u003c\/strong\u003e Monitor blood cell counts regularly; neutropenia is a significant risk.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUse in Pregnancy: \u003c\/strong\u003ePregnant women should not use Paclitaxel due to potential harm to the fetus.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLiver Function:\u003c\/strong\u003e Monitor liver function regularly, as impaired liver function can increase toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtravasation: \u003c\/strong\u003eEnsure proper drug administration to avoid tissue damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAlopecia (hair loss)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMucositis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePeripheral neuropathy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnaphylaxis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSevere neutropenia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCardiovascular issues, including hypotension\u003c\/li\u003e\n\u003cli\u003eSevere hypersensitivity reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients and caregivers need to maintain vigilant monitoring for side effects during treatment, with prompt communication with healthcare providers to manage and mitigate adverse reactions.\u003c\/p\u003e\n\u003cp\u003eIn summary, Paclitaxel Injection by Pfizer Injectables is an essential chemotherapy agent known for its potent action against cancer cells. Its reliable formulation and stringent safety measures provide a transformative approach to cancer treatment, albeit with necessary precautions based on its potent pharmacologic profile.\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":51853219561840,"sku":"61703-0342-09","price":18.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Paclitaxel-Injection-6-mg-by-Pfizer-Injectables.jpg?v=1739193956"},{"product_id":"mercaptopurine-tablets-50-mg-usp-25-count","title":"Mercaptopurine Tablets 50 mg USP 25 Count","description":"\u003cp\u003eMercaptopurine Tablets by Hikma are a critical component in the management of certain leukemias. These tablets provide a reliable oral chemotherapy option aimed at inhibiting cancer cell proliferation in acute lymphoblastic leukemia (ALL).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUsage:\u003c\/strong\u003e Mercaptopurine is primarily used in the treatment of acute lymphoblastic leukemia. It may also be prescribed as part of maintenance therapy in suitable regimens for other hematologic cancers.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard Dosage:\u003c\/strong\u003e Typically 1.5 to 2.5 mg\/kg of body weight per day, administered as a single dose.\u003c\/li\u003e\n\u003cli\u003eDosage adjustments may be necessary based on tolerance and response.\u003c\/li\u003e\n\u003cli\u003eAlways follow the specific dosing instructions provided by a healthcare provider.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e The CDC highlights the importance of individualized cancer treatment plans and regular monitoring of blood counts during chemotherapy. Proper handling and administration procedures should be followed to ensure patient safety and efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 50 mg per tablet\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCount:\u003c\/strong\u003e 25 tablets per bottle\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOral Chemotherapy:\u003c\/strong\u003e Convenient for outpatient management\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEffective Leukemia Management:\u003c\/strong\u003e Targets cell proliferation in hematologic malignancies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e Mercaptopurine interferes with nucleotide synthesis by incorporating into DNA and RNA, inhibiting the synthesis and function of purine nucleotides. This disrupts the growth and replication of cancer cells, leading to cell death.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTake tablets orally with or without food.\u003c\/li\u003e\n\u003cli\u003eMaintain a consistent dosing schedule as prescribed by the healthcare provider.\u003c\/li\u003e\n\u003cli\u003eRegular blood tests are required to monitor response and adjust dosage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMonitor liver function and blood counts regularly due to the risk of toxicity.\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with hepatic or renal impairment.\u003c\/li\u003e\n\u003cli\u003eAvoid use in patients with known hypersensitivity to mercaptopurine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e Possible side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBone marrow suppression\u003c\/li\u003e\n\u003cli\u003eLiver toxicity\u003c\/li\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eVomiting\u003c\/li\u003e\n\u003cli\u003eRash In the case of severe adverse reactions, seek immediate medical assistance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eMercaptopurine Tablets by Hikma provide a trusted and effective option in the fight against leukemia, supporting patient outcomes through targeted therapeutic action.\u003c\/em\u003e\u003c\/p\u003e","brand":"Hikma","offers":[{"title":"Default Title","offer_id":52232626602352,"sku":"00054-4581-11","price":49.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Mercaptopurine-Tablets-50-mg-by-Hikma-label.jpg?v=1746106806"},{"product_id":"allopurinol-sodium-500-mg-powder-vial","title":"Allopurinol Sodium Injection 500 mg, Single-Use Vial, Sterile (RX)","description":"\u003cp\u003eAllopurinol sodium injection (brand name Aloprim) is a medication used to control elevated uric acid levels in the blood, particularly in patients undergoing chemotherapy who are unable to take oral allopurinol. It is administered intravenously in a hospital or clinical setting.\u003c\/p\u003e\n\u003cp\u003eAllopurinol Sodium Injection is a medication used to manage and treat high levels of uric acid in the blood, commonly seen in conditions such as cancer therapy-induced tumor lysis syndrome. It works by inhibiting the enzyme xanthine oxidase, which is involved in the production of uric acid. This form is used when oral administration is not feasible, allowing for rapid intervention and management in an acute setting. It’s important to be administered under the guidance of a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eAllopurinol Sodium for Injection by Hikma Injectables is a sterile, high-quality formulation specifically designed for intravenous use. This 500 mg single-use vial is intended for the management of elevated uric acid levels associated with chemotherapy, ensuring rapid and effective control.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis injectable form of Allopurinol is used to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePrevent acute uric acid nephropathy in patients with leukemia, lymphoma, and solid tumor malignancies undergoing chemotherapy\u003c\/li\u003e\n\u003cli\u003eManage elevated uric acid levels in patients unable to take oral medication\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTypically, the dosage is determined by the healthcare provider based on the patient’s specific needs and condition. It's crucial to follow the prescribed dosage to avoid complications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWhile the CDC does not provide specific guidelines for Allopurinol, they emphasize the importance of managing uric acid levels to prevent complications in chemotherapy patients.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 500 mg of Allopurinol Sodium per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Sterile, single-use vial for intravenous infusion\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand:\u003c\/strong\u003e Hikma Injectables\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAllopurinol acts by inhibiting xanthine oxidase, an enzyme involved in the conversion of hypoxanthine and xanthine to uric acid. This reduces uric acid production, helping prevent kidney damage and other complications associated with high uric acid levels.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eFor intravenous infusion only.\u003c\/li\u003e\n\u003cli\u003eReconstitute the vial with appropriate diluent before administration.\u003c\/li\u003e\n\u003cli\u003eAdminister under the supervision of a healthcare professional.\u003c\/li\u003e\n\u003cli\u003eUse immediately after preparation to ensure sterility.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eHypersensitivity reactions may occur; discontinue if any severe reactions appear.\u003c\/li\u003e\n\u003cli\u003eFor hospital and clinical settings only.\u003c\/li\u003e\n\u003cli\u003eNot for use in patients who have demonstrated hypersensitivity to Allopurinol.\u003c\/li\u003e\n\u003cli\u003eMonitor renal function regularly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSome potential side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRash or allergic reactions\u003c\/li\u003e\n\u003cli\u003eGastrointestinal disturbances (nausea, vomiting)\u003c\/li\u003e\n\u003cli\u003eAltered liver function tests\u003c\/li\u003e\n\u003cli\u003eInfusion site reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConsult Healthcare Provider:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAlways ensure that Allopurinol is administered under the guidance of a qualified healthcare professional. Monitor kidney and liver function regularly to detect any adverse effects promptly. Discontinue use and seek medical attention if serious side effects occur.\u003c\/p\u003e","brand":"Hikma Injectables","offers":[{"title":"Default Title","offer_id":52264568488304,"sku":"00143-9533-01","price":6795.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Allopurinol-Sodium-500-mg-for-Injection.jpg?v=1747049822"},{"product_id":"ll-37-antimicrobial-peptide-immune-anti-inflammatory-gut-digestive-health","title":"LL-37 Antimicrobial Peptide Injection Bioactive Therapy 4 mg","description":"\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003eThis product needs to be purchased from our Partner company Skydell Medical. Set up an account here to Buy: \u003c\/span\u003e\u003ca href=\"https:\/\/www.skydellmedical.com\/ref\/click\/G9SAFPGL\" title=\"Create Account\" target=\"_blank\"\u003e **Create Account Here\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Get-Started-Buying.jpg?v=1760983627\" alt=\"get started\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003eLL-37 is an antimicrobial peptide, part of the cathelicidin family, produced by immune cells and epithelial cells in the human body. It plays a key role in the innate immune response.\u003c\/p\u003e\n\u003ch3\u003eLL-37 Peptide Benefits:\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAntimicrobial Activity\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad-Spectrum Defense\u003c\/strong\u003e: LL-37 is effective against various pathogens including bacteria, viruses, and fungi.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune Enhancement\u003c\/strong\u003e: Boosts the body's natural ability to fight infections.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWound Healing\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Regeneration\u003c\/strong\u003e: Promotes the growth of new cells, aiding in the repair of damaged tissues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Wounds\u003c\/strong\u003e: Beneficial for conditions like diabetic ulcers by accelerating recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImmune Modulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInflammation Control\u003c\/strong\u003e: Helps balance inflammatory responses, reducing excessive inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutoimmune Disorders\u003c\/strong\u003e: Potential therapeutic benefits for conditions like rheumatoid arthritis by modulating immune activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSkin Health\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBarrier Protection\u003c\/strong\u003e: Strengthens the skin's defense mechanisms, making it resilient to environmental stressors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Skin Conditions\u003c\/strong\u003e: Supports improvement in eczema, psoriasis, and rosacea symptoms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAnti-Inflammatory Properties\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Cytokine Production\u003c\/strong\u003e: Lowers pro-inflammatory cytokines, alleviating chronic inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions\u003c\/strong\u003e: May help in managing allergic responses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAnticancer Potential\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTumor Suppression\u003c\/strong\u003e: Some studies indicate LL-37’s potential to inhibit tumor growth and spread.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is LL-37 Antimicrobial Peptide?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLL-37 is a naturally occurring antimicrobial peptide in the human immune system. Known for its broad-spectrum antimicrobial properties, it plays a key role in the body’s defense against pathogens, including bacteria, viruses, and fungi.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow It Works:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePathogen Defense:\u003c\/strong\u003e LL-37 disrupts microbial membranes, effectively neutralizing harmful pathogens.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune System Modulation:\u003c\/strong\u003e Modulates immune responses, reducing inflammation and supporting healing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair:\u003c\/strong\u003e Promotes wound healing and tissue regeneration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWho Needs LL-37 Peptide?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndividuals with Compromised Immunity:\u003c\/strong\u003e To enhance immune defense and reduce infection risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAthletes:\u003c\/strong\u003e For faster recovery and reduced inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHealth Enthusiasts:\u003c\/strong\u003e Seeking improved overall health and protective benefits.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Skydell Medical","offers":[{"title":"Default Title","offer_id":52616901558640,"sku":"Call to Buy 1-888-687-4334","price":100.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/LL-37-Antimicrobial-Peptide-Injection-Bioactive-Therapy-4-mg.jpg?v=1760886556"},{"product_id":"plerixafor-injection-20mg-ml-stem-cell-mobilizer-single-dose-vial-2-ml","title":"Plerixafor Injection 20mg\/mL Hematopoietic Stem Cell Mobilizer Single-Dose Vial 2 mL by Amneal (RX)","description":"\u003ch4\u003e\u003cstrong\u003ePremium Plerixafor Stem Cell Mobilizer for Hematopoietic Stem Cell Transplantation\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003ePlerixafor Injection 20mg\/mL by Amneal Pharmaceuticals is a leading, FDA-approved stem cell mobilizer designed for use in patients with certain types of non-Hodgkin’s lymphoma and multiple myeloma. Plerixafor, in combination with granulocyte-colony stimulating factor (G-CSF), enhances the release of CD34+ hematopoietic stem cells from the bone marrow into peripheral blood for efficient collection and subsequent stem cell transplantation.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eWith its proven efficacy and high purity, this single-dose 2 mL vial (total 40mg) ensures reliability and safety for adult and pediatric patients undergoing autologous hematopoietic stem cell transplantation (HSCT).\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eHealth Benefits \u0026amp; Clinical Advantages\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStimulates Rapid Stem Cell Mobilization:\u003c\/strong\u003e Facilitates the movement of hematopoietic stem cells (HSCs) into circulating blood, ensuring optimal cell harvest for autologous transplantation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproves Stem Cell Collection Results:\u003c\/strong\u003e Increases chances of successful transplantation outcomes for patients with lymphoma and multiple myeloma who do not respond adequately to G-CSF alone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOptimal for HSCT:\u003c\/strong\u003e Essential adjunct for bone marrow transplant candidates, supporting the recovery and regeneration of blood and immune systems after chemotherapy or radiation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Purity, Consistency, and FDA-Recommended:\u003c\/strong\u003e Manufactured under stringent quality controls by Amneal Pharmaceuticals to ensure consistent performance and patient safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose Convenience:\u003c\/strong\u003e Each 2 mL vial contains 20mg\/mL (total 40mg) for easy, accurate dosing and reduced medication waste.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSpecific FDA-Labeled Uses\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e For use in combination with G-CSF to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage\/Administration:\u003c\/strong\u003e Administer subcutaneously as directed by a qualified healthcare professional. Refer to full prescribing information for specific dosing recommendations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Plerixafor Injection by Amneal Pharmaceuticals?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndustry-Leading Quality:\u003c\/strong\u003e Trusted by healthcare providers for oncology and hematology patients worldwide.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnhanced Patient Outcomes:\u003c\/strong\u003e Increases stem cell yields in patients where G-CSF alone is insufficient.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStreamlined Workflow for Transplant Teams:\u003c\/strong\u003e Single-dose, ready-to-use vial maximizes efficiency and minimizes preparation time.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced Risk of Collection Failure:\u003c\/strong\u003e Supports improved engraftment and transplantation success rates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eCompliance Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedication:\u003c\/strong\u003e Plerixafor Injection 20mg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 20mg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVolume:\u003c\/strong\u003e 2 mL single-dose vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC:\u003c\/strong\u003e 70121-1694-02\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUPC:\u003c\/strong\u003e 370121-169420\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Amneal Pharmaceuticals\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e For subcutaneous injection only; prescription required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTake Stem Cell Mobilization to the Next Level\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eEmpower your transplant protocols with Plerixafor Injection 20mg\/mL by Amneal Pharmaceuticals—a trusted solution for optimal stem cell mobilization and successful autologous hematopoietic stem cell transplantation.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Amneal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":52826320142704,"sku":"70121-1694-02","price":475.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Plerixafor-Injection-20mg-mL-Stem-Cell-Mobilizer-Single-Dose-Vial-2-mL.jpg?v=1767106937"},{"product_id":"releuko-filgrastim-ayow-injection-syringes-300mcg-0-5-ml-refrigerated-rx","title":"Releuko Filgrastim-Ayow Injection 300mcg\/0.5 mL Prefilled Syringes 27 gauge x 1\/2 inch Needle **Refrigerated (RX)","description":"\u003ch4\u003eAdvanced White Blood Cell Support with FDA-Approved Releuko® Filgrastim-ayow\u003c\/h4\u003e\n\u003cp\u003eReleuko® (filgrastim-ayow) Injection is a highly trusted, FDA-approved biosimilar to Neupogen® (filgrastim), designed to boost neutrophil (white blood cell) production for patients at risk of neutropenia, especially during chemotherapy, bone marrow transplant, or other cancer treatments. Each prefilled syringe contains a precise dose of 300mcg\/0.5 mL—equipped with an ultra-thin 27 gauge x 1\/2” needle—to ensure accurate, virtually painless administration.\u003c\/p\u003e\n\u003ch3\u003eIndications \u0026amp; Clinical Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemotherapy-Induced Neutropenia:\u003c\/strong\u003e Reduces infection risk and neutropenia duration in cancer patients receiving myelosuppressive chemotherapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow \u0026amp; Stem Cell Transplantation:\u003c\/strong\u003e Aids in the mobilization and recovery of hematopoietic stem cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere Chronic Neutropenia:\u003c\/strong\u003e For patients with congenital, cyclic, or idiopathic neutropenia to maintain safe neutrophil levels.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer Supportive Therapy:\u003c\/strong\u003e Assists oncology teams in improving treatment initiation and maintenance by minimizing chemotherapy delays due to low ANC.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eHealth Benefits \u0026amp; Key Clinical Features\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Neutrophil Recovery:\u003c\/strong\u003e Clinically proven to raise absolute neutrophil count (ANC) and decrease the duration of severe neutropenia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Risk of Infection:\u003c\/strong\u003e Minimizes life-threatening infections in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy or undergoing bone marrow or stem cell transplantation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiosimilar Efficacy \u0026amp; Affordability:\u003c\/strong\u003e Offers the same safety, strength, and potency as Neupogen® at a lower cost—improving access to advanced oncology care.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrefilled Syringe Convenience:\u003c\/strong\u003e Designed for ease of use, safer dosing, and accurate self-administration by patients or caregivers at home or in the clinic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLatex-Free, Ready-to-Use:\u003c\/strong\u003e Sterile, single-dose prefilled syringes reduce preparation errors and cross-contamination risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBacked by Amneal Quality:\u003c\/strong\u003e Manufactured under strict GMP standards for optimal purity, safety, and reliability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Releuko® by Amneal BioServices?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAffordable Biosimilar:\u003c\/strong\u003e FDA-approved alternative, ensuring access to cost-effective, high-quality biologic therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose Precision:\u003c\/strong\u003e Each prefilled syringe delivers an accurate 300 mcg dose, simplifying the injection process and minimizing dosing mistakes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePatient-Focused Design:\u003c\/strong\u003e Ultra-fine 27G x 1\/2” needle is designed for patient comfort and minimal injection pain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliability \u0026amp; Safety:\u003c\/strong\u003e Amneal’s world-class manufacturing ensures a product that meets strict quality, sterility, and efficacy standards.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDosage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 300mcg\/0.5mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Subcutaneous or intravenous injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeedle:\u003c\/strong\u003e 27 gauge x 1\/2 inch\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInstructions:\u003c\/strong\u003e To be administered by a healthcare provider or as directed in your treatment plan. Refer to full Prescribing Information for dosing protocols by indication.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eImportant Compliance \u0026amp; Product Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand:\u003c\/strong\u003e Releuko® (filgrastim-ayow), Amneal BioServices\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC:\u003c\/strong\u003e 70121-1568-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUPC:\u003c\/strong\u003e 370121156819\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Prefilled syringes, latex-free\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength per Syringe:\u003c\/strong\u003e 300mcg\/0.5 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIncludes:\u003c\/strong\u003e 27G x 1\/2\" needled syringes, packaging for safe transport and storage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSupport Your Oncology Journey with Trusted Releuko® Injection\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eReleuko® (filgrastim-ayow) Injection\u003c\/strong\u003e is a leader in cancer supportive care, helping patients maintain healthier white blood cell counts and continue their treatment journey stronger and safer. Choose Releuko or recommend it to your care team for advanced \u003cstrong\u003einfection prevention\u003c\/strong\u003e, optimized \u003cstrong\u003eneutrophil recovery\u003c\/strong\u003e, and comprehensive oncology support.\u003c\/p\u003e","brand":"Amneal BioServices","offers":[{"title":"Default Title","offer_id":52826348683632,"sku":"70121-1568-01","price":295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Releuko-Filgrastim-ayow-Injection-Syringes-300mcg.jpg?v=1767108610"},{"product_id":"bortezomib-injection-3-5mg-vial-single-dose-by-somerset-pharma-rx","title":"Bortezomib Injection 3.5mg Vial, Single Dose by Somerset Pharma (RX)","description":"\u003ch1\u003eBortezomib 3.5 mg Injection (Single-Dose Vial)\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eBortezomib is a chemotherapy drug (a \u003cstrong\u003eproteasome inhibitor\u003c\/strong\u003e) used to treat certain blood cancers. It works by blocking the 26S proteasome inside cells, preventing the breakdown of proteins that trigger cell death. Cancer cells (especially myeloma cells) cannot survive when this proteasome is inhibited, so they undergo apoptosis. Brand names include Velcade® (bortezomib for injection).\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eUses: \u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eBortezomib injection is FDA-approved for adults with multiple myeloma and mantle cell lymphoma. It is often given in combination with other chemotherapy (e.g. dexamethasone, melphalan, cyclophosphamide, etc.). It may be used as initial therapy, or for relapsed\/refractory disease after prior treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eFormulation and Dosage\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Each vial contains \u003cstrong\u003e3.5 mg\u003c\/strong\u003e of bortezomib as a sterile lyophilized (freeze-dried) powder. There are no preservatives, so each vial is \u003cstrong\u003esingle-use only\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReconstitution:\u003c\/strong\u003e The powder must be dissolved in 0.9% sodium chloride (sterile saline) before injection. For \u003cstrong\u003eintravenous (IV)\u003c\/strong\u003e administration, add \u003cstrong\u003e3.5 mL\u003c\/strong\u003e saline to the 3.5 mg vial (yielding 1.0 mg\/mL). For \u003cstrong\u003esubcutaneous (SC)\u003c\/strong\u003e (under-the-skin) use, add \u003cstrong\u003e1.4 mL\u003c\/strong\u003e saline (yielding 2.5 mg\/mL). Gently mix to dissolve (do \u003cstrong\u003enot shake vigorously\u003c\/strong\u003e). Use the reconstituted solution \u003cstrong\u003eimmediately\u003c\/strong\u003e (the drug has no preservative) and discard any unused portion within about \u003cstrong\u003e8 hours\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eDosage:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eThe typical \u003cstrong\u003estarting dose\u003c\/strong\u003e is \u003cstrong\u003e1.3 mg\/m²\u003c\/strong\u003e of body surface area, given as either a rapid IV push (3–5 seconds) or an SC injection. Treatment schedules vary, but a common regimen is twice weekly on days 1, 4, 8, and 11 of a 21-day cycle, followed by a 10-day rest. Dose adjustments may be needed for patients with liver impairment or other factors. Your doctor will calculate the exact dose and schedule; do not change the dose on your own.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eAdministration: \u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eBortezomib is given only by healthcare professionals in a clinic or hospital. Do not attempt to self-inject unless specifically trained. It can be given into a peripheral vein or via a central line. Rotating injection sites (for SC) can help reduce local irritation. Since IV and SC concentrations differ, double-check the preparation before giving any dose. Important: Bortezomib must never be administered intrathecally (into the spine) – this is contraindicated and can be fatal.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eSide Effects and Precautions\u003c\/h2\u003e\n\u003cp\u003eBortezomib has several potential side effects. Some of the most common (occurring in ≥20% of patients) include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal:\u003c\/strong\u003e Nausea, vomiting, diarrhea or constipation are very common. Your doctor may prescribe anti-nausea or anti-diarrheal medications if needed. Staying hydrated and eating small frequent meals can help manage these effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Cell Counts:\u003c\/strong\u003e Bortezomib suppresses bone marrow. You may develop \u003cstrong\u003ethrombocytopenia\u003c\/strong\u003e (low platelets) or \u003cstrong\u003eneutropenia\u003c\/strong\u003e (low white cells). This raises the risk of bleeding or infection. \u003cstrong\u003eRegular blood tests (CBC)\u003c\/strong\u003e are required before each dose to monitor your counts. Notify your provider if you see unusual bruising, bleeding, or signs of infection (fever, sore throat).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuropathy (Nerve Effects):\u003c\/strong\u003e Many patients experience \u003cstrong\u003eperipheral neuropathy\u003c\/strong\u003e – tingling, numbness or burning in the hands and feet. This can cause pain or weakness, and may worsen if not addressed. Report any new numbness, tingling, or difficulty walking to your doctor promptly. In severe cases, the dose may need to be reduced or delayed. Ask your doctor about strategies to protect your nerves (such as avoiding extreme cold or drugs that worsen neuropathy).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue and General:\u003c\/strong\u003e Tiredness, weakness, loss of appetite, fever, and rash are also fairly common. Rest when needed. Over-the-counter pain relievers (as recommended by your doctor) or cool showers may help with fatigue or fever.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypotension and Dizziness:\u003c\/strong\u003e Bortezomib can cause low blood pressure. If you feel dizzy when standing, get up slowly and drink plenty of fluids. Patients on blood pressure medication or who become dehydrated should be cautious.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHerpes Zoster (Shingles):\u003c\/strong\u003e Bortezomib significantly increases the risk of shingles (reactivation of herpes zoster). In clinical trials, 6–11% of bortezomib-treated patients developed shingles. Your doctor will likely prescribe antiviral medication (e.g. acyclovir) to prevent this. \u003cstrong\u003eDiscuss antiviral prophylaxis with your provider\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Warnings:\u003c\/strong\u003e Though less common, bortezomib can cause serious problems. These include heart failure or heart damage, severe lung problems, and a rare brain condition called Posterior Reversible Encephalopathy Syndrome (PRES), which involves headaches, vision changes, or seizures. Always report any chest pain, sudden shortness of breath, severe headache, confusion, or other alarming symptoms immediately. Bortezomib may also cause birth defects – effective birth control is essential for both men and women during treatment.\u003c\/p\u003e\n\u003ch2\u003eMonitoring and Follow-Up\u003c\/h2\u003e\n\u003cp\u003eYour healthcare team will monitor you closely during bortezomib therapy:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLaboratory Tests:\u003c\/strong\u003e Blood counts and liver function tests are checked before each dose. Your doctor may also monitor blood glucose if you have diabetes. If blood counts fall too low, the doctor may delay or reduce the next dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhysical Exams:\u003c\/strong\u003e Numbness in the hands\/feet is checked, blood pressure is measured regularly. Tell your doctor about any new, worsening, or unusual symptoms (numbness, bleeding, rash, severe nausea, mood changes, etc.).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedications:\u003c\/strong\u003e Review all your medicines with the doctor – some drugs can interact with bortezomib. For example, strong CYP3A4 inhibitors (like certain antifungals or antibiotics) or inducers (like rifampin) can alter bortezomib levels. Also inform your doctor about any herbal supplements or over-the-counter products.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccination\/Prophylaxis:\u003c\/strong\u003e Because bortezomib weakens the immune system, expect to avoid live vaccines during treatment. Annual flu shots (inactivated vaccine) and pneumonia vaccines are often recommended before starting therapy. Antiviral prophylaxis (as mentioned) and sometimes Pneumocystis pneumonia prophylaxis may be given.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eStorage and Handling\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBefore Use:\u003c\/strong\u003e Store unopened vials at \u003cstrong\u003eroom temperature\u003c\/strong\u003e (68–77°F\/20–25°C) in the original carton, protected from light. Avoid excessive heat or freezing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAfter Reconstitution:\u003c\/strong\u003e Once mixed with saline, bortezomib solution should be kept at room temperature and used within \u003cstrong\u003e8 hours\u003c\/strong\u003e. It may be stored at up to 77°F (25°C) in the vial or syringe during that time. Do \u003cstrong\u003enot freeze\u003c\/strong\u003e the reconstituted solution and \u003cstrong\u003edo not use after 8 hours\u003c\/strong\u003e. Discard any remaining solution after a single patient use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrecautions:\u003c\/strong\u003e Handle the drug carefully (wear gloves) and dispose of needles\/syringes safely. Keep all chemotherapy agents out of reach of children and pets.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003ePatient Tips and Key Advice\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevent Nausea \u0026amp; Diarrhea:\u003c\/strong\u003e Eat small, bland meals and sip clear liquids. Take prescribed anti-nausea pills or antidiarrheal meds as directed. Staying hydrated (water, electrolyte drinks) helps reduce dizziness and gastrointestinal upset.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManage Neuropathy:\u003c\/strong\u003e Let your doctor know immediately if you feel burning, tingling, or loss of feeling in hands or feet. Use non-slip slippers and handrails to prevent falls. Protect your hands\/feet from extreme temperatures and avoid alcohol, which can worsen nerve symptoms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitor Blood Sugar:\u003c\/strong\u003e If you have diabetes, check your blood glucose more often. Bortezomib can affect blood sugar control. Your diabetes medicines may need adjustment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStay Active (Safely):\u003c\/strong\u003e Light exercise (walking, stretching) can help combat fatigue and nerve symptoms, but listen to your body. Rest when you feel very tired.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevent Infections:\u003c\/strong\u003e Practice good hand hygiene and avoid crowds or sick people. Report fever, cough, or any sign of infection right away.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvoid Pregnancy:\u003c\/strong\u003e Use effective birth control during treatment and for the advised period afterward. Bortezomib can cause fetal harm. Men should also use condoms to avoid fathering a pregnancy on treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAsk About Prophylaxis:\u003c\/strong\u003e Remind your doctor to prescribe antiviral medication to prevent shingles. If you haven’t had chickenpox or shingles before, you may discuss vaccines with your doctor prior to therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo Not Share Doses:\u003c\/strong\u003e Each vial is for one patient and one use. Never use leftover drug on another day or another person.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReport Reactions:\u003c\/strong\u003e Immediately tell your provider if you have a sudden rash, trouble breathing, severe back pain, or any allergic symptoms after the injection. Emergency care is needed for these.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eArrange Support:\u003c\/strong\u003e Because bortezomib can cause fatigue or dizziness, plan to have someone drive you home after treatment if you feel lightheaded.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways follow your healthcare team’s instructions exactly. Keep all appointments and lab tests, and communicate any concerns. This information is a general guide; your doctor and pharmacist will give you detailed counseling tailored to your health needs.\u003c\/p\u003e","brand":"Somerset Therapeutics","offers":[{"title":"Default Title","offer_id":53715938050416,"sku":"70069-0836-01","price":22.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Bortezomib-for-Injection-3_5-gram-somerset.jpg?v=1777985942"},{"product_id":"carboplatin-injection-10-mg-ml-50-mg-multiple-dose-amber-vial","title":"Carboplatin Injection 10 mg\/mL, 50 mg Multiple-Dose Amber Vial (RX)","description":"\u003ch1\u003eCarboplatin Injection 10 mg\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin is a platinum-based alkylating (chemotherapy) agent (a cisplatin analog) used to treat certain cancers. Each 5 mL vial contains 50 mg carboplatin (10 mg\/mL) in sterile, pyrogen-free solution. Mannitol (10 mg\/mL) is included as a stabilizer. The solution is clear and colorless to pale yellow.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eMechanism of Action:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin forms reactive platinum complexes that cross-link DNA (interstrand and intrastrand), inhibiting DNA synthesis. It is cell-cycle non-specific, damaging cells during division.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eIndications:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eIt is FDA-approved (Rx-only) primarily for ovarian carcinoma. Specifically, carboplatin is indicated for \u003cstrong\u003efirst-line treatment of advanced epithelial ovarian cancer\u003c\/strong\u003e (usually given with other chemotherapeutic agents). It’s also indicated for \u003cstrong\u003epalliative treatment of recurrent ovarian cancer\u003c\/strong\u003e after prior chemotherapy (including cases previously treated with cisplatin). Off-label, carboplatin is frequently used in regimens for other solid tumors (often combined with other drugs) such as lung cancer (especially small-cell lung cancer), cervical cancer, bladder cancer, testicular cancer, head \u0026amp; neck cancers, and various gynecologic tumors.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eDosage and Administration\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute\u003c\/strong\u003e: Intravenous infusion only. Typical infusions last ≥15 minutes. No special hydration or forced diuresis is required (unlike cisplatin).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTypical Dosing\u003c\/strong\u003e: For example, single-agent therapy in recurrent ovarian cancer often uses ~360 mg\/m² IV on day 1 every 4 weeks. In combination with cyclophosphamide for first-line ovarian cancer, a regimen might use carboplatin ~300 mg\/m² IV on day 1 (with cyclophosphamide 600 mg\/m² IV) every 4 weeks. Dosing should be individualized; the \u003cstrong\u003eCalvert formula\u003c\/strong\u003e is commonly employed to adjust dose by renal function:\n\u003cblockquote\u003e\n\u003cp\u003e\u003cem\u003eDose (mg) = target AUC × (GFR + 25)\u003c\/em\u003e. This accounts for the patient’s creatinine clearance (glomerular filtration rate, GFR). Patients with diminished kidney function (creatinine clearance \u0026lt;60 mL\/min) require dose reduction or formula adjustment. As with most cytotoxics, administration should be delayed if the patient’s neutrophils are \u0026lt;2000\/mm³ or platelets are \u0026lt;100,000\/mm³; repeat dosing is often held until counts recover to at least those levels.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfusion Preparation\u003c\/strong\u003e: Inspect the solution visually before use. Compatible IV fluids include 0.9% NaCl or 5% dextrose (avoid aluminum-containing equipment). \u003cstrong\u003eDo not use needles or IV sets with aluminum parts\u003c\/strong\u003e (aluminum reacts with carboplatin and causes precipitates\/loss of potency). After drawing from the vial, any diluted infusion should be administered promptly (discard prepared infusions after 8 hours).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003ePackaging and Storage\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eContainer\u003c\/strong\u003e: Each 50 mg dose is supplied as a 5 mL multiple-dose \u003cstrong\u003eamber glass vial\u003c\/strong\u003e (NDC 55150-333-01). The amber color and labeling (“\u003cem\u003eProtect from light\u003c\/em\u003e”) shield the light-sensitive solution. The vial has a gray\/flipped cap allowing multiple needle entries.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage Conditions\u003c\/strong\u003e: Store unopened vials at controlled room temperature (20–25 °C or 68–77 °F) and keep them tightly closed. Do not freeze. Because the solution can degrade with light, keep the vial in its carton or cover it to avoid light exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAfter Opening\u003c\/strong\u003e: Once punctured, the multi-dose vial remains stable for up to \u003cstrong\u003e14 days\u003c\/strong\u003e at 20–25 °C (if stored light-protected). After 14 days the vial should be discarded. (This short in-use shelf-life is a consequence of using it without preservative.) Any prepared infusion bag should be used within 8 hours.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWarnings and Precautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration Supervision\u003c\/strong\u003e: Carboplatin is a potent chemotherapeutic. It should only be administered by a qualified oncologist or healthcare provider experienced in cancer chemotherapy. Appropriate supportive facilities (for transfusions, anti-emetics, emergency care) must be readily available.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHematologic Toxicity\u003c\/strong\u003e: The \u003cstrong\u003ebox warning\u003c\/strong\u003e highlights that bone marrow suppression is dose-related and can be severe. Severe leukopenia\/neutropenia, thrombocytopenia, and anemia can occur. Monitor blood counts closely. Reductions in dose or delays in treatment may be needed; as noted, do not give the next cycle until neutrophils ≥2000\/mm³ and platelets ≥100,000\/mm³. Anemia may be cumulative over multiple cycles and could require blood transfusions. Patients should be observed for signs of infection or bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity\u003c\/strong\u003e: Anaphylactic-type reactions have been reported, sometimes occurring on first dose. Be prepared to treat severe allergic reactions immediately (e.g. with epinephrine, corticosteroids, antihistamines). If a reaction occurs, discontinue the drug.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNausea\/Vomiting\u003c\/strong\u003e: Carboplatin often causes moderate-to-severe nausea and vomiting. Premedication with antiemetics is recommended (e.g. serotonin antagonists, corticosteroids) according to standard chemotherapy practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Function\u003c\/strong\u003e: Carboplatin is primarily excreted by the kidneys. Unlike cisplatin, it usually does not require aggressive hydration; nevertheless \u003cem\u003eserious\u003c\/em\u003e renal toxicity, while uncommon, has been reported (e.g. tubular necrosis). Development of significant serum creatinine elevations is uncommon (~6% of cases). Renal function (creatinine clearance) should be assessed before dosing. Reduce the dose if creatinine clearance is \u0026lt;60 mL\/min. Carboplatin’s clearance is directly proportional to GFR, so formula dosing is important in renal impairment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHearing (Ototoxicity)\u003c\/strong\u003e: Carboplatin can cause hearing loss (ototoxicity), especially at high doses or with other ototoxic drugs (aminoglycosides, etc.). Audiometric monitoring is advised for patients (particularly children) receiving large doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Fertility\u003c\/strong\u003e: Carboplatin can cause fetal harm. In animal studies it was teratogenic and embryotoxic. Pregnant women or women of childbearing potential should be warned of these risks; effective contraception is essential. It is commonly considered Pregnancy Category D. Men and women should avoid conceiving during and for some time after treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther Concerns\u003c\/strong\u003e: Use caution in patients with hepatic impairment (dose adjustments unknown). Carboplatin may exacerbate neurologic or electrolyte abnormalities (e.g. hypomagnesemia or seizures) when used with other ToxicAgents. Concurrent use with phenytoin or warfarin may decrease their levels (monitor accordingly).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eAdverse Effects\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHematologic\u003c\/strong\u003e: As noted, dose-limiting neutropenia, thrombocytopenia and anemia are common. The nadir (lowest point) in blood counts typically occurs ~3–4 weeks after a dose. Monitor CBC regularly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal\u003c\/strong\u003e: Nausea and vomiting are frequent (often delayed nausea 1–3 days post-dose), so anti-emetic prophylaxis is standard. Mucositis, anorexia, diarrhea or constipation can also occur.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal\/Hepatic\u003c\/strong\u003e: Renal toxicity is uncommon but should be monitored (creatinine and BUN). Mild liver enzyme elevations can occur.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensory\u003c\/strong\u003e: Ototoxicity (hearing loss, tinnitus) and peripheral neuropathy are possible, especially with high cumulative doses. These are usually less severe than with cisplatin, but baseline and periodic hearing tests are prudent, especially in children.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral\u003c\/strong\u003e: Fatigue, headache, fever, rash or itching may occur. Alopecia (hair loss) is common. Injection reactions at the infusion site (pain, phlebitis) can happen.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHandling and Disposal\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHazardous Drug Precautions\u003c\/strong\u003e: Carboplatin is a hazardous cytotoxic agent. When preparing or administering it, healthcare workers should follow standard chemotherapy handling guidelines. Wear gloves and gowns; if spills occur, clean thoroughly. If the solution contacts skin, wash the area immediately with soap and water; flush eyes or mucous membranes with water if exposed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisposal\u003c\/strong\u003e: Dispose of unused drug and containers according to institutional policies for antineoplastic waste. Do not reuse syringes or vials.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Teva Pharmaceuticals","offers":[{"title":"Default Title","offer_id":53827878322544,"sku":"00703-4244-01","price":12.75,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Carboplatin-Injection-10-mg-teva.jpg?v=1779373550"},{"product_id":"kyxata-carboplatin-10-mg-intravenous-chemotherapy-multiple-dose-vial-8-ml-rx0","title":"Kyxata Carboplatin 10 mg Intravenous Chemotherapy Multiple-Dose Vial 8 mL (Rx)","description":"\u003ch1\u003eKyxata (Carboplatin) 10 mg\/mL Injection\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cem\u003eKyxata\u003c\/em\u003e is a brand of \u003cstrong\u003ecarboplatin injection\u003c\/strong\u003e, a platinum-based chemotherapy drug. It comes as a sterile pale-yellow solution where each milliliter (mL) contains 10 mg of carboplatin. (Vial strengths include 20 mg\/2 mL, 80 mg\/8 mL, and 500 mg\/50 mL, all at 10 mg\/mL.) Carboplatin works by binding DNA and forming cross-links, blocking DNA replication and causing cancer cell death.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eUses (Indications)\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvanced ovarian cancer (first-line):\u003c\/strong\u003e Kyxata is used \u003cstrong\u003ewith other chemotherapy agents\u003c\/strong\u003e (e.g. cyclophosphamide) as initial treatment for advanced ovarian carcinoma in adults.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecurrent ovarian cancer:\u003c\/strong\u003e It is also indicated as a \u003cstrong\u003esingle agent\u003c\/strong\u003e for ovarian carcinoma that has recurred after prior chemotherapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDosage and Administration\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Given only by intravenous infusion (usually by an oncologist or in a cancer clinic). It is \u003cstrong\u003enot\u003c\/strong\u003e a self-administered drug.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose calculation:\u003c\/strong\u003e Dosing is based on body size and kidney function. Doctors often use the Calvert formula: \u003cem\u003eDose (mg) = Target AUC (area under curve) × (GFR + 25)\u003c\/em\u003e, where GFR (glomerular filtration rate) is estimated from creatinine clearance. This ensures the dose is adjusted for each patient’s renal function.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTypical dosing:\u003c\/strong\u003e For example, an initial regimen might be \u003cstrong\u003e300 mg\/m²\u003c\/strong\u003e (or targeting an AUC of 4–6 mg·min\/mL) on Day 1, combined with cyclophosphamide, every 4 weeks (for up to 6 cycles). For recurrent disease as a single agent, around \u003cstrong\u003e360 mg\/m²\u003c\/strong\u003e (or AUC 4–6) on Day 1 every 4 weeks is common. Exact doses will be determined by the treating oncologist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Complete blood counts are checked before each cycle because carboplatin can severely lower blood cell levels. Anti-nausea medications are usually given before the infusion to prevent vomiting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects and Precautions\u003c\/h2\u003e\n\u003cp\u003eKyxata has serious potential side effects, as with most chemotherapy agents. Key points include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMyelosuppression (low blood counts):\u003c\/strong\u003e The most important toxicity is \u003cem\u003ebone marrow suppression\u003c\/em\u003e. This drug commonly causes neutropenia (low white cells), thrombocytopenia (low platelets), and anemia. This can lead to severe infections, bleeding, or fatigue. Doctors monitor blood counts closely and may delay or reduce doses if counts are too low.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNausea and vomiting:\u003c\/strong\u003e These are common. Patients are typically given antiemetics (anti-vomiting drugs) before and after treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic reactions:\u003c\/strong\u003e Kyxata can cause \u003cem\u003esevere hypersensitivity\u003c\/em\u003e, including anaphylactic reactions, sometimes within minutes of starting the infusion. Medical staff will watch for any rash, difficulty breathing, or other allergic signs during administration. If a serious reaction occurs, the infusion is stopped immediately and managed appropriately.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeripheral neuropathy:\u003c\/strong\u003e Tingling, numbness, or weakness in the hands or feet can occur. Dose adjustments may be needed if neuropathy develops.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther common effects:\u003c\/strong\u003e Hair loss (alopecia) and fatigue are very common. Other frequent side effects include nausea, anemia, low platelet count, and low magnesium or sodium levels.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and fertility:\u003c\/strong\u003e Carboplatin can cause fetal harm. Women of childbearing potential must use effective contraception and avoid pregnancy during treatment. Men should also use contraception. Breastfeeding is not recommended.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e Avoid concurrent use of certain drugs, especially \u003cstrong\u003eaminoglycoside antibiotics\u003c\/strong\u003e (e.g. gentamicin). Using these together with carboplatin can increase the risk of kidney damage or hearing loss. Your doctor or pharmacist will check all medications to prevent harmful interactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eImportant Information\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical super­vision required:\u003c\/strong\u003e Kyxata is a prescription medication administered only under a doctor’s care. Do \u003cem\u003enot\u003c\/em\u003e attempt to use it on your own.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Frequent lab tests (blood counts, kidney function, electrolytes) are needed before and during treatment. The doctor will adjust dosing or delay cycles based on these results.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsult professionals:\u003c\/strong\u003e This summary is for general information. Individual dosing and safety measures depend on a patient’s health status and should be managed by oncologists or pharmacists. For full prescribing details, healthcare providers can refer to official sources (e.g. FDA’s Daily Med listing for Kyxata).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eDisclaimer:\u003c\/em\u003e This information is not medical advice. For personal medical concerns or before starting any medication, please consult a licensed healthcare professional.\u003c\/p\u003e","brand":"Mountainside Medical","offers":[{"title":"Default Title","offer_id":53827933962608,"sku":"83831-0141-08","price":625.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Kyxata-Carboplatin-10-mg-Intravenous-Chemotherapy.jpg?v=1779375414"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/Cancer-Treating-Drugs.jpg?v=1729510883","url":"https:\/\/www.mountainside-medical.com\/collections\/cancer-treating-drugs\/pfizer-injectables+carboplatin-mechanism-of-action.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}